882 is the total number of securities DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) has owned. The longest DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) has owned a single stock is 36 quarters.
Period | Weighting | Quarter | |||||||
---|---|---|---|---|---|---|---|---|---|
Ticker | Name | Longest | Shortest | Min. | Avg. | Max. | First | Latest | ↓ Count |
AERI | AERIE PHARMACEUTICALS INC | 36 | 36 | 0.14% | 1.37% | 3.58% | Q4 2013 | Q3 2022 | 36 |
CNC | CENTENE CORP DEL | 23 | 1 | 0.32% | 1.47% | 3.02% | Q4 2013 | Q3 2023 | 30 |
BCRX | BIOCRYST PHARMACEUTICA... | 23 | 3 | 0.07% | 0.82% | 2.23% | Q3 2013 | Q3 2023 | 29 |
MOH | MOLINA HEALTHCARE INC | 16 | 1 | 0.47% | 0.82% | 1.71% | Q2 2013 | Q3 2022 | 26 |
EHTH | EHEALTH INC | 24 | 1 | 0.30% | 1.14% | 2.03% | Q1 2014 | Q3 2020 | 25 |
INTERCEPT PHARMACEUTIC... | 15 | 9 | 0.92% | 1.37% | 2.19% | Q1 2017 | Q1 2023 | 24 | |
MYL | MYLAN NV | 23 | 23 | 0.02% | 3.46% | 6.17% | Q1 2015 | Q3 2020 | 23 |
PTLA | PORTOLA PHARMACEUTICAL... | 19 | 4 | 0.15% | 1.65% | 5.96% | Q2 2013 | Q1 2019 | 23 |
BKD | BROOKDALE SR LIVING INC | 22 | 1 | 0.46% | 1.10% | 2.23% | Q3 2015 | Q3 2023 | 23 |
ALIM | ALIMERA SCIENCES INC | 23 | 23 | 0.16% | 0.37% | 0.80% | Q1 2014 | Q3 2019 | 23 |
DBVT | DBV TECHNOLOGIES S A | 16 | 6 | 0.16% | 1.37% | 2.94% | Q4 2014 | Q2 2020 | 22 |
DCPH | DECIPHERA PHARMACEUTIC... | 20 | 2 | 0.28% | 0.89% | 2.02% | Q3 2017 | Q3 2023 | 22 |
SEM | SELECT MED HLDGS CORP | 15 | 1 | 0.02% | 0.64% | 1.29% | Q4 2013 | Q4 2020 | 22 |
ARDX | ARDELYX INC | 22 | 22 | 0.09% | 0.47% | 1.68% | Q1 2016 | Q2 2021 | 22 |
BPMC | BLUEPRINT MEDICINES CORP | 17 | 4 | 0.25% | 1.02% | 2.13% | Q3 2016 | Q4 2021 | 21 |
PRTO | PROTEON THERAPEUTICS INC | 21 | 21 | 0.01% | 0.27% | 0.80% | Q4 2014 | Q4 2019 | 21 |
NEOS | NEOS THERAPEUTICS INC | 12 | 9 | 0.00% | 0.18% | 0.65% | Q3 2015 | Q4 2020 | 21 |
MYOK | MYOKARDIA INC | 20 | 20 | 0.17% | 1.32% | 2.64% | Q4 2015 | Q3 2020 | 20 |
EDIT | EDITAS MEDICINE INC | 20 | 20 | 0.68% | 1.29% | 2.51% | Q1 2016 | Q4 2020 | 20 |
IMMU | IMMUNOMEDICS INC | 13 | 1 | 0.13% | 1.23% | 4.77% | Q1 2014 | Q3 2020 | 20 |
GKOS | GLAUKOS CORP | 12 | 3 | 0.00% | 1.17% | 3.76% | Q2 2016 | Q3 2022 | 20 |
BLUE | BLUEBIRD BIO INC | 9 | 1 | 0.15% | 0.91% | 2.80% | Q3 2013 | Q1 2023 | 20 |
HZNP | HORIZON PHARMA PLC | 19 | 19 | 2.47% | 6.44% | 14.19% | Q3 2014 | Q1 2019 | 19 |
XLRN | ACCELERON PHARMA INC | 17 | 2 | 0.40% | 1.31% | 2.42% | Q4 2015 | Q3 2021 | 19 |
RYTM | RHYTHM PHARMACEUTICALS... | 19 | 19 | 0.02% | 0.89% | 3.14% | Q4 2017 | Q2 2022 | 19 |
GLPG | GALAPAGOS NV | 18 | 1 | 0.45% | 0.78% | 1.27% | Q2 2015 | Q2 2021 | 19 |
ALEC | ALECTOR INC | 19 | 19 | 0.14% | 0.60% | 1.40% | Q1 2019 | Q3 2023 | 19 |
OXFD | OXFORD IMMUNOTEC GLOBA... | 15 | 4 | 0.04% | 0.39% | 0.85% | Q1 2015 | Q4 2020 | 19 |
HORIZON PHARMA INVT LTD | 18 | 18 | 2.71% | 4.24% | 8.17% | Q1 2016 | Q2 2020 | 18 | |
NXTM | NXSTAGE MEDICAL INC | 18 | 18 | 1.96% | 3.37% | 5.13% | Q2 2013 | Q3 2017 | 18 |
NEVRO CORP | 18 | 18 | 1.05% | 3.07% | 5.36% | Q4 2016 | Q1 2021 | 18 | |
AXGN | AXOGEN INC | 13 | 1 | 0.03% | 0.58% | 1.43% | Q3 2014 | Q1 2020 | 18 |
GWPH | GW PHARMACEUTICALS PLC | 16 | 1 | 0.17% | 1.83% | 6.22% | Q2 2014 | Q4 2018 | 17 |
ORTX | ORCHARD THERAPEUTICS PLC | 17 | 17 | 0.02% | 1.78% | 5.50% | Q4 2018 | Q4 2022 | 17 |
XENT | INTERSECT ENT INC | 17 | 17 | 0.08% | 1.46% | 2.54% | Q2 2017 | Q2 2021 | 17 |
AET | AETNA INC NEW | 10 | 2 | 0.50% | 1.46% | 2.83% | Q2 2013 | Q2 2018 | 17 |
AACH | AAC HLDGS INC | 17 | 17 | 0.11% | 0.87% | 1.93% | Q1 2015 | Q1 2019 | 17 |
BDSI | BIODELIVERY SCIENCES I... | 8 | 1 | 0.00% | 0.56% | 1.37% | Q2 2013 | Q4 2021 | 17 |
FOMX | FOAMIX PHARMACEUTICALS... | 17 | 17 | 0.05% | 0.24% | 0.56% | Q3 2014 | Q3 2018 | 17 |
AHCO | ADAPTHEALTH CORP | 16 | 16 | 0.65% | 3.43% | 8.73% | Q4 2019 | Q3 2023 | 16 |
ARRY | ARRAY BIOPHARMA INC | 16 | 16 | 0.39% | 1.79% | 3.06% | Q2 2013 | Q1 2017 | 16 |
ARRAY BIOPHARMA INC | 16 | 16 | 1.03% | 1.55% | 2.57% | Q2 2013 | Q1 2017 | 16 | |
UAM | UNIVERSAL AMERN CORP NEW | 16 | 16 | 1.04% | 1.50% | 1.93% | Q2 2013 | Q1 2017 | 16 |
MCK | MCKESSON CORP | 9 | 2 | 0.67% | 1.47% | 5.04% | Q1 2014 | Q2 2020 | 16 |
ANAB | ANAPTYSBIO INC | 11 | 5 | 0.27% | 1.30% | 3.22% | Q1 2017 | Q2 2023 | 16 |
SILK | SILK ROAD MEDICAL INC | 11 | 5 | 0.14% | 1.26% | 2.27% | Q2 2019 | Q2 2023 | 16 |
SWTX | SPRINGWORKS THERAPEUTI... | 11 | 5 | 0.32% | 0.90% | 2.07% | Q3 2019 | Q3 2023 | 16 |
RETA | REATA PHARMACEUTICALS INC | 16 | 16 | 0.27% | 0.75% | 1.19% | Q3 2017 | Q2 2021 | 16 |
MRTX | MIRATI THERAPEUTICS INC | 11 | 2 | 0.03% | 0.71% | 2.25% | Q1 2015 | Q1 2022 | 16 |
SYRS | SYROS PHARMACEUTICALS INC | 16 | 16 | 0.24% | 0.67% | 1.50% | Q2 2016 | Q1 2020 | 16 |
PACB | PACIFIC BIOSCIENCES CA... | 11 | 1 | 0.02% | 0.66% | 1.44% | Q2 2013 | Q1 2023 | 16 |
INSM | INSMED INC | 9 | 1 | 0.10% | 0.65% | 1.57% | Q2 2013 | Q2 2023 | 16 |
CABA | CABALETTA BIO INC | 16 | 16 | 0.01% | 0.21% | 0.78% | Q4 2019 | Q3 2023 | 16 |
FLML | FLAMEL TECHNOLOGIES SA | 15 | 15 | 1.25% | 2.26% | 3.24% | Q2 2013 | Q4 2016 | 15 |
MNKKQ | MALLINCKRODT PUB LTD CO | 7 | 1 | 0.05% | 1.81% | 5.12% | Q3 2014 | Q3 2020 | 15 |
VNDA | VANDA PHARMACEUTICALS INC | 15 | 15 | 0.33% | 1.56% | 2.66% | Q3 2013 | Q1 2017 | 15 |
INFI | INFINITY PHARMACEUTICA... | 14 | 1 | 0.10% | 1.43% | 2.85% | Q2 2013 | Q1 2017 | 15 |
MIRM | MIRUM PHARMACEUTICALS INC | 15 | 15 | 0.82% | 1.40% | 2.70% | Q3 2019 | Q1 2023 | 15 |
PCRX | PACIRA PHARMACEUTICALS... | 8 | 1 | 0.07% | 1.05% | 2.54% | Q2 2015 | Q4 2022 | 15 |
ANTM | ANTHEM INC | 7 | 3 | 0.08% | 0.98% | 2.03% | Q1 2015 | Q2 2019 | 15 |
RVMD | REVOLUTION MEDICINES INC | 15 | 15 | 0.36% | 0.93% | 1.65% | Q1 2020 | Q3 2023 | 15 |
NSTG | NANOSTRING TECHNOLOGIE... | 15 | 15 | 0.13% | 0.39% | 0.63% | Q3 2013 | Q1 2017 | 15 |
CASM | CAS MED SYS INC | 15 | 15 | 0.10% | 0.21% | 0.28% | Q3 2013 | Q1 2017 | 15 |
DVA | DAVITA INC | 12 | 2 | 0.98% | 1.61% | 2.57% | Q4 2013 | Q1 2018 | 14 |
LRMR | LARIMAR THERAPEUTICS INC | 14 | 14 | 0.24% | 1.35% | 2.18% | Q2 2020 | Q3 2023 | 14 |
XNCR | XENCOR INC | 14 | 14 | 0.06% | 1.16% | 2.52% | Q1 2015 | Q2 2018 | 14 |
BOLD | AUDENTES THERAPEUTICS INC | 14 | 14 | 0.42% | 1.08% | 1.92% | Q3 2016 | Q4 2019 | 14 |
ISEE | IVERIC BIO INC | 14 | 14 | 0.25% | 1.02% | 1.84% | Q4 2019 | Q1 2023 | 14 |
LOXO | LOXO ONCOLOGY INC | 14 | 14 | 0.23% | 0.62% | 1.22% | Q3 2014 | Q4 2017 | 14 |
WVE | WAVE LIFE SCIENCES LTD | 7 | 3 | 0.04% | 0.47% | 0.74% | Q4 2016 | Q4 2021 | 14 |
STDY | STEADYMED LTD | 14 | 14 | 0.14% | 0.24% | 0.48% | Q1 2015 | Q2 2018 | 14 |
STRM | STREAMLINE HEALTH SOLU... | 14 | 14 | 0.03% | 0.15% | 0.33% | Q4 2013 | Q1 2017 | 14 |
NBIX | NEUROCRINE BIOSCIENCES... | 11 | 2 | 0.03% | 2.40% | 4.05% | Q1 2014 | Q3 2023 | 13 |
INSMED INC | 11 | 1 | 0.93% | 1.60% | 2.37% | Q1 2020 | Q3 2023 | 13 | |
ENDOLOGIX INC | 13 | 13 | 0.49% | 1.28% | 1.90% | Q1 2014 | Q1 2017 | 13 | |
AFIB | ACUTUS MED INC | 13 | 13 | 0.04% | 0.71% | 3.15% | Q3 2020 | Q3 2023 | 13 |
RARX | RA PHARMACEUTICALS INC | 13 | 13 | 0.03% | 0.70% | 2.28% | Q4 2016 | Q4 2019 | 13 |
PTC THERAPEUTICS INC NOTE | 13 | 13 | 0.28% | 0.58% | 1.06% | Q2 2019 | Q2 2022 | 13 | |
CTMX | CYTOMX THERAPEUTICS INC | 13 | 13 | 0.38% | 0.58% | 0.80% | Q4 2015 | Q4 2018 | 13 |
SIEN | SIENTRA INC | 12 | 1 | 0.01% | 0.55% | 1.21% | Q1 2018 | Q4 2022 | 13 |
XERIS PHARMACEUTICALS INC | 13 | 13 | 0.35% | 0.49% | 0.88% | Q2 2020 | Q2 2023 | 13 | |
IVTY | INVUITY INC | 13 | 13 | 0.10% | 0.39% | 0.82% | Q2 2015 | Q2 2018 | 13 |
RIGL | RIGEL PHARMACEUTICALS INC | 13 | 13 | 0.11% | 0.24% | 0.43% | Q2 2013 | Q2 2016 | 13 |
ANNX | ANNEXON INC | 13 | 13 | 0.03% | 0.23% | 1.19% | Q3 2020 | Q3 2023 | 13 |
GNCA | GENOCEA BIOSCIENCES INC | 13 | 13 | 0.11% | 0.22% | 0.49% | Q1 2014 | Q1 2017 | 13 |
ATEC | ALPHATEC HOLDINGS INC | 13 | 13 | 0.05% | 0.22% | 0.42% | Q2 2013 | Q2 2016 | 13 |
BIOS | BIOSCRIP INC | 11 | 2 | 0.03% | 0.21% | 0.51% | Q3 2013 | Q4 2018 | 13 |
SCYX | SCYNEXIS INC | 12 | 1 | 0.05% | 0.15% | 0.20% | Q2 2014 | Q1 2018 | 13 |
VYGR | VOYAGER THERAPEUTICS INC | 13 | 13 | 0.04% | 0.10% | 0.21% | Q4 2015 | Q4 2018 | 13 |
VTRS | VIATRIS INC | 12 | 12 | 1.81% | 4.32% | 5.90% | Q4 2020 | Q3 2023 | 12 |
WBA | WALGREENS BOOTS ALLIAN... | 9 | 3 | 0.41% | 1.33% | 2.00% | Q1 2015 | Q2 2018 | 12 |
ACRS | ACLARIS THERAPEUTICS INC | 12 | 12 | 0.14% | 1.18% | 2.17% | Q3 2016 | Q2 2019 | 12 |
ARGX | ARGENX SE | 12 | 12 | 0.52% | 1.17% | 1.88% | Q2 2017 | Q1 2020 | 12 |
HUM | HUMANA INC | 4 | 1 | 0.48% | 0.97% | 2.22% | Q2 2013 | Q4 2019 | 12 |
FATE | FATE THERAPEUTICS INC | 9 | 3 | 0.42% | 0.88% | 1.25% | Q3 2018 | Q3 2021 | 12 |
ASND | ASCENDIS PHARMA A S | 10 | 2 | 0.01% | 0.85% | 1.39% | Q1 2015 | Q1 2019 | 12 |
FLUIDIGM CORP DEL | 12 | 12 | 0.33% | 0.74% | 1.03% | Q4 2014 | Q3 2017 | 12 | |
ATEC | ALPHATEC HOLDINGS INC | 11 | 1 | 0.11% | 0.60% | 1.06% | Q3 2019 | Q2 2023 | 12 |
CNST | CONSTELLATION PHARMCET... | 12 | 12 | 0.01% | 0.51% | 0.96% | Q3 2018 | Q2 2021 | 12 |
COGT | COGENT BIOSCIENCES INC | 12 | 12 | 0.18% | 0.50% | 1.09% | Q4 2020 | Q3 2023 | 12 |
KMPH | KEMPHARM INC | 9 | 3 | 0.00% | 0.39% | 1.14% | Q2 2015 | Q1 2020 | 12 |
NVTA | INVITAE CORP | 8 | 1 | 0.05% | 0.35% | 0.84% | Q1 2015 | Q1 2023 | 12 |
AGRX | AGILE THERAPEUTICS INC | 7 | 1 | 0.02% | 0.09% | 0.24% | Q2 2014 | Q3 2019 | 12 |
PTN | PALATIN TECHNOLOGIES INC | 12 | 12 | 0.02% | 0.06% | 0.10% | Q2 2013 | Q1 2016 | 12 |
INVITAE CORP | 10 | 1 | 0.32% | 3.43% | 6.52% | Q3 2020 | Q2 2023 | 11 | |
TABULA RASA HEALTHCARE... | 11 | 11 | 0.73% | 1.90% | 3.12% | Q1 2021 | Q3 2023 | 11 | |
KEMPHARM INC | 11 | 11 | 1.10% | 1.71% | 2.36% | Q1 2017 | Q3 2019 | 11 | |
ADPTQ | ADEPTUS HEALTH INC | 11 | 11 | 0.08% | 1.42% | 3.25% | Q3 2014 | Q1 2017 | 11 |
DYAX | DYAX CORP | 11 | 11 | 0.11% | 1.42% | 3.42% | Q2 2013 | Q4 2015 | 11 |
ATRS | ANTARES PHARMA INC | 11 | 11 | 0.20% | 1.18% | 2.35% | Q2 2013 | Q4 2015 | 11 |
VCEL | VERICEL CORP | 10 | 1 | 0.04% | 1.11% | 2.60% | Q3 2018 | Q3 2022 | 11 |
EWTX | EDGEWISE THERAPEUTICS INC | 11 | 11 | 0.50% | 1.04% | 2.69% | Q1 2021 | Q3 2023 | 11 |
LUNG | PULMONX CORP | 8 | 3 | 0.23% | 1.04% | 2.05% | Q4 2020 | Q3 2023 | 11 |
ACCURAY INC | 11 | 11 | 0.82% | 1.03% | 1.26% | Q2 2013 | Q4 2015 | 11 | |
XERS | XERIS PHARMACEUTICALS INC | 9 | 2 | 0.21% | 0.90% | 1.70% | Q2 2018 | Q2 2021 | 11 |
AVDL | AVADEL PHARMACEUTICALS... | 11 | 11 | 0.15% | 0.89% | 2.15% | Q1 2017 | Q3 2019 | 11 |
RCKT | ROCKET PHARMACEUTICALS... | 10 | 1 | 0.03% | 0.47% | 1.57% | Q1 2018 | Q3 2022 | 11 |
ITMR | ITAMAR MED LTD | 11 | 11 | 0.11% | 0.28% | 0.60% | Q1 2019 | Q3 2021 | 11 |
STIM | NEURONETICS INC | 10 | 1 | 0.07% | 0.14% | 0.24% | Q2 2018 | Q1 2021 | 11 |
MDVL | MEDAVAIL HOLDINGS INC | 11 | 11 | 0.00% | 0.10% | 0.34% | Q4 2020 | Q2 2023 | 11 |
BFLYWS | BUTTERFLY NETWORK INC | 11 | 11 | 0.00% | 0.02% | 0.10% | Q1 2021 | Q3 2023 | 11 |
NUVBWS | NUVATION BIO INC | 11 | 11 | 0.00% | 0.00% | 0.01% | Q1 2021 | Q3 2023 | 11 |
GLAUKOS CORP | 10 | 10 | 2.53% | 6.43% | 9.40% | Q2 2021 | Q3 2023 | 10 | |
NATERA INC | 10 | 10 | 1.02% | 2.55% | 3.66% | Q2 2021 | Q3 2023 | 10 | |
CMAX | CAREMAX INC | 10 | 10 | 0.74% | 1.98% | 3.84% | Q2 2021 | Q3 2023 | 10 |
HEALTHWAYS INC | 10 | 10 | 0.25% | 1.68% | 3.68% | Q4 2014 | Q1 2017 | 10 | |
APELLIS PHARMACEUTICAL... | 9 | 1 | 0.64% | 1.45% | 2.14% | Q3 2020 | Q1 2023 | 10 | |
NVRO | NEVRO CORP | 4 | 1 | 0.37% | 1.44% | 2.60% | Q4 2014 | Q4 2021 | 10 |
ALLSCRIPTS HEALTHCARE ... | 5 | 5 | 0.34% | 1.36% | 3.86% | Q4 2014 | Q1 2018 | 10 | |
XNPT | XENOPORT INC | 6 | 4 | 0.46% | 1.32% | 3.20% | Q2 2013 | Q2 2016 | 10 |
OMIC | SINGULAR GENOMICS SYST... | 10 | 10 | 0.04% | 1.10% | 4.45% | Q2 2021 | Q3 2023 | 10 |
CLOVIS ONCOLOGY INC | 7 | 1 | 0.18% | 1.01% | 1.72% | Q4 2016 | Q2 2021 | 10 | |
NTRA | NATERA INC | 4 | 3 | 0.37% | 0.89% | 1.27% | Q3 2017 | Q3 2020 | 10 |
KURA | KURA ONCOLOGY INC | 10 | 10 | 0.60% | 0.86% | 1.59% | Q2 2021 | Q3 2023 | 10 |
ARVN | ARVINAS INC | 10 | 10 | 0.13% | 0.77% | 1.55% | Q3 2018 | Q4 2020 | 10 |
NEVRO CORP NOTE | 10 | 10 | 0.37% | 0.77% | 1.46% | Q2 2020 | Q3 2022 | 10 | |
ARNA | ARENA PHARMACEUTICALS INC | 10 | 10 | 0.30% | 0.74% | 1.31% | Q2 2013 | Q3 2015 | 10 |
GRAY | GRAYBUG VISION INC | 10 | 10 | 0.06% | 0.68% | 3.03% | Q3 2020 | Q4 2022 | 10 |
KALV | KALVISTA PHARMACEUTICA... | 5 | 5 | 0.27% | 0.59% | 0.97% | Q3 2018 | Q1 2022 | 10 |
EPZM | EPIZYME INC | 10 | 10 | 0.13% | 0.58% | 0.94% | Q2 2016 | Q3 2018 | 10 |
HEALTH CATALYST INC | 10 | 10 | 0.28% | 0.50% | 0.63% | Q2 2021 | Q3 2023 | 10 | |
AKTX | AKARI THERAPEUTICS PLC | 10 | 10 | 0.04% | 0.47% | 1.07% | Q3 2015 | Q4 2017 | 10 |
SYBX | SYNLOGIC INC | 9 | 1 | 0.02% | 0.38% | 0.73% | Q3 2017 | Q1 2020 | 10 |
DSCO | DISCOVERY LABORATORIES... | 10 | 10 | 0.08% | 0.19% | 0.43% | Q2 2013 | Q3 2015 | 10 |
ALPN | ALPINE IMMUNE SCIENCES... | 10 | 10 | 0.03% | 0.19% | 0.49% | Q3 2017 | Q4 2019 | 10 |
ARLZ | ARALEZ PHARMACEUTICALS... | 10 | 10 | 0.02% | 0.18% | 0.37% | Q1 2016 | Q2 2018 | 10 |
CMAXW | CAREMAX INC | 10 | 10 | 0.00% | 0.02% | 0.06% | Q2 2021 | Q3 2023 | 10 |
QSIAW | QUANTUM SI INC | 10 | 10 | 0.00% | 0.01% | 0.02% | Q2 2021 | Q3 2023 | 10 |
WINT | WINDTREE THERAPEUTICS INC | 10 | 10 | 0.00% | 0.00% | 0.00% | Q2 2020 | Q3 2022 | 10 |
NUVALENT INC | 9 | 9 | 5.41% | 10.81% | 20.25% | Q3 2021 | Q3 2023 | 9 | |
AVXS | AVEXIS INC | 9 | 9 | 2.59% | 4.95% | 10.12% | Q1 2016 | Q1 2018 | 9 |
FIXX | HOMOLOGY MEDICINES INC | 9 | 9 | 1.99% | 3.93% | 5.56% | Q1 2018 | Q1 2020 | 9 |
TRINITY BIOTECH INVT LTD | 9 | 9 | 1.24% | 1.66% | 2.18% | Q2 2016 | Q2 2018 | 9 | |
ENDOLOGIX INC | 7 | 2 | 1.21% | 1.48% | 1.83% | Q4 2015 | Q2 2018 | 9 | |
SRPT | SAREPTA THERAPEUTICS INC | 8 | 1 | 0.27% | 1.23% | 1.76% | Q2 2018 | Q4 2021 | 9 |
KERX | KERYX BIOPHARMACEUTICA... | 8 | 1 | 0.31% | 1.12% | 2.40% | Q2 2013 | Q4 2016 | 9 |
OMI | OWENS & MINOR INC NEW | 5 | 4 | 0.33% | 1.08% | 2.29% | Q2 2020 | Q3 2023 | 9 |
NVLS | NIVALIS THERAPEUTICS INC | 9 | 9 | 0.34% | 0.99% | 1.88% | Q2 2015 | Q2 2017 | 9 |
TNDM | TANDEM DIABETES CARE INC | 9 | 9 | 0.06% | 0.92% | 2.59% | Q1 2018 | Q1 2020 | 9 |
SAGE | SAGE THERAPEUTICS INC | 7 | 1 | 0.19% | 0.79% | 1.52% | Q3 2014 | Q3 2017 | 9 |
GBT | GLOBAL BLOOD THERAPEUT... | 6 | 3 | 0.10% | 0.76% | 1.52% | Q3 2015 | Q4 2019 | 9 |
DAWN | DAY ONE BIOPHARMACEUTI... | 7 | 2 | 0.32% | 0.57% | 1.30% | Q2 2021 | Q3 2023 | 9 |
ONCR | ONCORUS INC | 9 | 9 | 0.01% | 0.52% | 1.82% | Q4 2020 | Q4 2022 | 9 |
TERN | TERNS PHARMACEUTICALS INC | 5 | 4 | 0.16% | 0.48% | 1.08% | Q1 2021 | Q2 2023 | 9 |
INZY | INOZYME PHARMA INC | 9 | 9 | 0.11% | 0.46% | 0.82% | Q3 2020 | Q3 2022 | 9 |
NUVB | NUVATION BIO INC | 5 | 4 | 0.01% | 0.41% | 0.69% | Q1 2021 | Q2 2023 | 9 |
BDTX | BLACK DIAMOND THERAPEU... | 7 | 2 | 0.06% | 0.37% | 0.66% | Q1 2020 | Q3 2023 | 9 |
TPTX | TURNING POINT THERAPEU... | 5 | 4 | 0.11% | 0.36% | 0.73% | Q2 2019 | Q3 2021 | 9 |
PROF | PROFOUND MED CORP | 9 | 9 | 0.06% | 0.33% | 0.55% | Q3 2020 | Q3 2022 | 9 |
PFNX | PFENEX INC | 7 | 2 | 0.09% | 0.19% | 0.34% | Q3 2014 | Q2 2019 | 9 |
NYXOAH S A | 9 | 9 | 0.05% | 0.11% | 0.22% | Q3 2021 | Q3 2023 | 9 | |
EUCRU | EUCRATES BIOMEDICAL AC... | 5 | 4 | 0.00% | 0.09% | 0.21% | Q4 2020 | Q1 2023 | 9 |
OCRX | OCERA THERAPEUTICS INC | 5 | 4 | 0.01% | 0.08% | 0.14% | Q4 2013 | Q4 2016 | 9 |
MTACU | MEDTECH ACQUISITION CORP | 6 | 3 | 0.00% | 0.07% | 0.21% | Q4 2020 | Q2 2023 | 9 |
SOMALOGIC INC | 9 | 9 | 0.00% | 0.00% | 0.01% | Q3 2021 | Q3 2023 | 9 | |
SURROZEN INC | 9 | 9 | 0.00% | 0.00% | 0.00% | Q3 2021 | Q3 2023 | 9 | |
HZNP | HORIZON THERAPEUTICS P... | 6 | 2 | 0.52% | 4.00% | 7.18% | Q2 2019 | Q2 2022 | 8 |
AERIE PHARMACEUTICALS INC | 7 | 1 | 2.73% | 2.98% | 3.40% | Q3 2020 | Q3 2022 | 8 | |
INTEGRA LIFESCIENCES H... | 8 | 8 | 1.77% | 1.93% | 2.30% | Q2 2013 | Q1 2015 | 8 | |
GSK | GLAXOSMITHKLINE PLC | 7 | 1 | 0.67% | 1.86% | 3.40% | Q3 2014 | Q1 2018 | 8 |
LCI | LANNET INC | 7 | 1 | 0.84% | 1.50% | 2.48% | Q2 2016 | Q2 2018 | 8 |
AMED | AMEDISYS INC | 5 | 1 | 0.06% | 1.18% | 3.50% | Q2 2013 | Q2 2023 | 8 |
ELGX | ENDOLOGIX INC | 7 | 1 | 0.20% | 0.99% | 1.86% | Q1 2014 | Q1 2016 | 8 |
MRUS | MERUS N V | 8 | 8 | 0.26% | 0.99% | 2.01% | Q4 2021 | Q3 2023 | 8 |
CYTK | CYTOKINETICS INC | 8 | 8 | 0.44% | 0.88% | 1.25% | Q4 2020 | Q3 2022 | 8 |
SPECTRANETICS CORP | 5 | 3 | 0.25% | 0.85% | 1.27% | Q2 2014 | Q2 2016 | 8 | |
PTGX | PROTAGONIST THERAPEUTI... | 7 | 1 | 0.18% | 0.61% | 1.09% | Q4 2017 | Q4 2021 | 8 |
RGNX | REGENXBIO INC | 4 | 4 | 0.26% | 0.56% | 1.14% | Q3 2015 | Q3 2018 | 8 |
OVAS | OVASCIENCE INC | 8 | 8 | 0.28% | 0.54% | 1.00% | Q2 2013 | Q1 2015 | 8 |
RAD | RITE AID CORP | 7 | 1 | 0.02% | 0.51% | 0.99% | Q2 2013 | Q3 2016 | 8 |
INGN | INOGEN INC | 6 | 2 | 0.08% | 0.44% | 0.89% | Q1 2014 | Q4 2019 | 8 |
ADVM | ADVERUM BIOTECHNOLOGIE... | 7 | 1 | 0.08% | 0.39% | 0.64% | Q1 2018 | Q2 2021 | 8 |
MEIP | MEI PHARMA INC | 8 | 8 | 0.05% | 0.35% | 0.53% | Q2 2013 | Q1 2015 | 8 |
DA32 LIFE SCNCE TEC AC... | 8 | 8 | 0.31% | 0.33% | 0.36% | Q3 2021 | Q2 2023 | 8 | |
AXGT | AXOVANT SCIENCES LTD | 5 | 1 | 0.20% | 0.31% | 0.40% | Q3 2015 | Q1 2019 | 8 |
THE ONCOLOGY INSTITUTE... | 8 | 8 | 0.04% | 0.30% | 0.72% | Q4 2021 | Q3 2023 | 8 | |
ESSA PHARMA INC | 8 | 8 | 0.04% | 0.27% | 0.45% | Q3 2015 | Q2 2017 | 8 | |
KNTE | KINNATE BIOPHARMA INC | 8 | 8 | 0.06% | 0.26% | 0.46% | Q4 2020 | Q3 2022 | 8 |
PSDV | PSIVIDA CORP | 8 | 8 | 0.01% | 0.14% | 0.24% | Q2 2015 | Q1 2017 | 8 |
DCTH | DELCATH SYS INC | 8 | 8 | 0.03% | 0.09% | 0.18% | Q4 2020 | Q3 2022 | 8 |
KIDS | ORTHOPEDIATRICS CORP | 7 | 1 | 0.03% | 0.09% | 0.34% | Q4 2017 | Q4 2019 | 8 |
CDNA | CAREDX INC | 8 | 8 | 0.01% | 0.09% | 0.21% | Q3 2014 | Q2 2016 | 8 |
THE ONCOLOGY INSTITUTE... | 8 | 8 | 0.00% | 0.01% | 0.03% | Q4 2021 | Q3 2023 | 8 | |
MTACW | MEDTECH ACQUISITION CORP | 8 | 8 | 0.00% | 0.00% | 0.01% | Q3 2021 | Q2 2023 | 8 |
AUXL | AUXILIUM PHARMACEUTICA... | 7 | 7 | 2.11% | 4.68% | 7.74% | Q2 2013 | Q4 2014 | 7 |
AGN | ALLERGAN INC | 7 | 7 | 0.78% | 2.15% | 4.63% | Q2 2013 | Q4 2014 | 7 |
NUVASIVE INC | 7 | 7 | 1.80% | 1.95% | 2.16% | Q2 2021 | Q4 2022 | 7 | |
PACIRA BIOSCIENCES INC | 7 | 7 | 1.52% | 1.77% | 2.26% | Q3 2021 | Q1 2023 | 7 | |
DXCM | DEXCOM INC | 6 | 1 | 0.36% | 1.56% | 3.46% | Q1 2017 | Q1 2020 | 7 |
HEARTWARE INTL INC | 7 | 7 | 0.75% | 1.25% | 1.56% | Q4 2014 | Q2 2016 | 7 | |
TEVA | TEVA PHARMACEUTICAL IN... | 3 | 1 | 0.01% | 1.25% | 2.30% | Q2 2013 | Q3 2016 | 7 |
WRIGHT MED GROUP N V | 7 | 7 | 0.65% | 1.12% | 1.63% | Q1 2018 | Q3 2019 | 7 | |
TRNX | TORNIER N V | 7 | 7 | 0.26% | 0.98% | 1.47% | Q2 2013 | Q4 2014 | 7 |
DFBHU | DFB HEALTHCARE ACQUIST... | 7 | 7 | 0.87% | 0.95% | 1.05% | Q1 2018 | Q3 2019 | 7 |
NUVASIVE INC | 5 | 1 | 0.27% | 0.93% | 2.82% | Q1 2018 | Q3 2020 | 7 | |
UHS | UNIVERSAL HLTH SVCS INC | 6 | 1 | 0.44% | 0.93% | 1.55% | Q4 2017 | Q1 2020 | 7 |
HWAY | HEALTHWAYS INC | 7 | 7 | 0.07% | 0.82% | 1.29% | Q2 2015 | Q4 2016 | 7 |
SEMA4 HOLDINGS CORP | 7 | 7 | 0.06% | 0.80% | 2.05% | Q3 2021 | Q1 2023 | 7 | |
ALNY | ALNYLAM PHARMACEUTICAL... | 2 | 1 | 0.25% | 0.73% | 1.14% | Q2 2013 | Q2 2018 | 7 |
VIVO | MERIDIAN BIOSCIENCE INC | 7 | 7 | 0.48% | 0.69% | 1.13% | Q2 2020 | Q4 2021 | 7 |
NOVAVAX INC | 7 | 7 | 0.48% | 0.69% | 0.86% | Q1 2021 | Q3 2022 | 7 | |
FPRX | FIVE PRIME THERAPEUTIC... | 6 | 1 | 0.19% | 0.67% | 1.18% | Q4 2015 | Q4 2017 | 7 |
ZBH | ZIMMER BIOMET HOLDINGS... | 3 | 1 | 0.29% | 0.66% | 1.20% | Q4 2016 | Q2 2021 | 7 |
IDYA | IDEAYA BIOSCIENCES INC | 5 | 2 | 0.15% | 0.64% | 1.35% | Q2 2019 | Q3 2023 | 7 |
OFIX | ORTHOFIX INTL N V | 7 | 7 | 0.47% | 0.63% | 0.78% | Q1 2014 | Q3 2015 | 7 |
ACHN | ACHILLION PHARMACEUTIC... | 2 | 1 | 0.00% | 0.57% | 1.28% | Q2 2013 | Q4 2015 | 7 |
IMPR | IMPRIVATA INC | 7 | 7 | 0.46% | 0.55% | 0.79% | Q3 2014 | Q1 2016 | 7 |
PHVS | PHARVARIS N V | 7 | 7 | 0.17% | 0.48% | 0.64% | Q1 2021 | Q3 2022 | 7 |
TRUP | TRUPANION INC | 7 | 7 | 0.06% | 0.44% | 0.67% | Q3 2014 | Q1 2016 | 7 |
OM | OUTSET MED INC | 5 | 2 | 0.12% | 0.29% | 0.41% | Q3 2020 | Q2 2022 | 7 |
AMWL | AMERICAN WELL CORP | 7 | 7 | 0.04% | 0.27% | 0.57% | Q3 2020 | Q1 2022 | 7 |
PMVP | PMV PHARMACEUTICALS INC | 7 | 7 | 0.00% | 0.25% | 0.49% | Q3 2020 | Q1 2022 | 7 |
DSCI | DERMA SCIENCES INC | 7 | 7 | 0.16% | 0.21% | 0.27% | Q1 2014 | Q3 2015 | 7 |
CATB | CATABASIS PHARMACEUTIC... | 7 | 7 | 0.09% | 0.18% | 0.30% | Q2 2015 | Q4 2016 | 7 |
QSI | QUANTUM SI INC | 6 | 1 | 0.03% | 0.15% | 0.30% | Q2 2021 | Q2 2023 | 7 |
FHTX | FOGHORN THERAPEUTICS INC | 7 | 7 | 0.08% | 0.12% | 0.22% | Q1 2022 | Q3 2023 | 7 |
KIN | KINDRED BIOSCIENCES INC | 6 | 1 | 0.06% | 0.12% | 0.28% | Q4 2013 | Q3 2015 | 7 |
SRSAU | SARISSA CAPITAL ACQUIS... | 4 | 3 | 0.00% | 0.12% | 0.23% | Q4 2020 | Q3 2022 | 7 |
TRILLIUM THERAPEUTICS INC | 7 | 7 | 0.06% | 0.10% | 0.15% | Q1 2015 | Q3 2016 | 7 | |
EYEN | EYENOVIA INC | 7 | 7 | 0.03% | 0.05% | 0.10% | Q1 2018 | Q3 2019 | 7 |
ROIVANT SCIENCES LTD | 7 | 7 | 0.01% | 0.03% | 0.05% | Q4 2021 | Q2 2023 | 7 | |
SNRHW | SENIOR CONNECT ACQUISI... | 7 | 7 | 0.00% | 0.00% | 0.01% | Q3 2021 | Q1 2023 | 7 |
DENDREON CORP | 6 | 6 | 3.98% | 5.40% | 6.29% | Q2 2013 | Q3 2014 | 6 | |
VOLCANO CORPORATION | 6 | 6 | 2.17% | 2.57% | 3.10% | Q2 2013 | Q3 2014 | 6 | |
ISIS PHARMACEUTICALS I... | 6 | 6 | 1.39% | 1.96% | 2.39% | Q4 2016 | Q1 2018 | 6 | |
GILD | GILEAD SCIENCES INC | 3 | 1 | 0.08% | 1.94% | 3.54% | Q2 2013 | Q3 2022 | 6 |
ABBV | ABBVIE INC | 3 | 1 | 1.20% | 1.87% | 2.91% | Q2 2013 | Q1 2015 | 6 |
ACCOLADE INC | 6 | 6 | 1.22% | 1.84% | 2.38% | Q2 2022 | Q3 2023 | 6 | |
INSULET CORP | 6 | 6 | 1.36% | 1.54% | 1.70% | Q1 2021 | Q2 2022 | 6 | |
ORGO | ORGANOGENESIS HLDGS INC | 6 | 6 | 0.45% | 1.48% | 2.13% | Q1 2021 | Q2 2022 | 6 |
NUVASIVE INC | 6 | 6 | 0.70% | 1.23% | 1.70% | Q1 2021 | Q2 2022 | 6 | |
RNA | PROSENSA HLDG N V | 6 | 6 | 0.74% | 1.11% | 2.23% | Q3 2013 | Q4 2014 | 6 |
GUARDANT HEALTH INC | 5 | 1 | 0.17% | 1.08% | 1.36% | Q4 2021 | Q2 2023 | 6 | |
AGN | ALLERGAN INC | 4 | 2 | 0.51% | 1.08% | 1.53% | Q2 2013 | Q4 2014 | 6 |
HILLEVAX INC | 6 | 6 | 0.59% | 0.98% | 1.22% | Q2 2022 | Q3 2023 | 6 | |
ONCE | SPARK THERAPEUTICS INC | 4 | 2 | 0.58% | 0.96% | 1.58% | Q1 2015 | Q1 2017 | 6 |
AXNX | AXONICS MODULATION TEC... | 5 | 1 | 0.24% | 0.94% | 1.45% | Q4 2019 | Q2 2023 | 6 |
LIVONGO HEALTH INC | 6 | 6 | 0.84% | 0.93% | 1.01% | Q2 2022 | Q3 2023 | 6 | |
ZLTQ | ZELTIQ AESTHETICS INC | 2 | 2 | 0.39% | 0.92% | 1.39% | Q1 2014 | Q2 2016 | 6 |
ZFGN | ZAFGEN INC | 6 | 6 | 0.22% | 0.83% | 1.35% | Q1 2015 | Q2 2016 | 6 |
KNSA | KINIKSA PHARMACEUTICAL... | 6 | 6 | 0.44% | 0.83% | 1.27% | Q2 2018 | Q3 2019 | 6 |
AGIO | AGIOS PHARMACEUTICALS INC | 5 | 1 | 0.20% | 0.74% | 1.04% | Q3 2013 | Q3 2018 | 6 |
ECYT | ENDOCYTE INC | 3 | 3 | 0.02% | 0.72% | 2.24% | Q2 2013 | Q3 2018 | 6 |
PTC THERAPEUTICS INC | 6 | 6 | 0.39% | 0.66% | 0.81% | Q2 2022 | Q3 2023 | 6 | |
REPH | RECRO PHARMA INC | 6 | 6 | 0.38% | 0.66% | 0.77% | Q4 2016 | Q1 2018 | 6 |
ADUS | ADDUS HOMECARE CORP | 6 | 6 | 0.16% | 0.59% | 0.82% | Q3 2018 | Q4 2019 | 6 |
PTCT | PTC THERAPEUTICS INC | 3 | 3 | 0.34% | 0.57% | 0.84% | Q3 2013 | Q3 2019 | 6 |
DNAI | PRONAI THERAPEUTICS INC | 6 | 6 | 0.07% | 0.56% | 1.09% | Q3 2015 | Q4 2016 | 6 |
IART | INTEGRA LIFESCIENCES H... | 3 | 1 | 0.13% | 0.55% | 0.95% | Q2 2013 | Q3 2023 | 6 |
BLU | BELLUS HEALTH INC NEW | 6 | 6 | 0.41% | 0.55% | 0.65% | Q4 2021 | Q1 2023 | 6 |
PBYI | PUMA BIOTECHNOLOGY INC | 4 | 2 | 0.11% | 0.54% | 0.80% | Q4 2019 | Q2 2021 | 6 |
RVNC | REVANCE THERAPEUTICS INC | 2 | 1 | 0.15% | 0.51% | 1.41% | Q1 2014 | Q3 2023 | 6 |
MOR | MORPHOSYS AG | 6 | 6 | 0.14% | 0.50% | 0.64% | Q2 2018 | Q3 2019 | 6 |
BHVN | BIOHAVEN PHARMACTL HLD... | 6 | 6 | 0.28% | 0.43% | 0.78% | Q2 2017 | Q3 2018 | 6 |
HOWL | WEREWOLF THERAPEUTICS INC | 6 | 6 | 0.08% | 0.31% | 0.79% | Q2 2021 | Q3 2022 | 6 |
LUMO | LUMOS PHARMA INC | 6 | 6 | 0.01% | 0.30% | 0.66% | Q1 2020 | Q2 2021 | 6 |
TELIGENT INC NEW | 6 | 6 | 0.18% | 0.28% | 0.37% | Q2 2018 | Q3 2019 | 6 | |
FUSN | FUSION PHARMACEUTICALS... | 3 | 3 | 0.04% | 0.27% | 0.64% | Q2 2020 | Q3 2023 | 6 |
TNXP | TONIX PHARMACEUTICALS ... | 5 | 1 | 0.10% | 0.26% | 0.41% | Q1 2014 | Q1 2016 | 6 |
LPDX | LIPOSCIENCE INC | 6 | 6 | 0.13% | 0.25% | 0.36% | Q2 2013 | Q3 2014 | 6 |
ADHD | ALCOBRA LTD | 6 | 6 | 0.17% | 0.23% | 0.27% | Q1 2015 | Q2 2016 | 6 |
SRRA | SIERRA ONCOLOGY INC | 6 | 6 | 0.13% | 0.21% | 0.29% | Q1 2017 | Q2 2018 | 6 |
ANTH | ANTHERA PHARMACEUTICAL... | 6 | 6 | 0.10% | 0.21% | 0.32% | Q3 2013 | Q4 2014 | 6 |
BCAB | BIOATLA INC | 6 | 6 | 0.03% | 0.17% | 0.27% | Q4 2020 | Q1 2022 | 6 |
TCON | TRACON PHARMACEUTICALS... | 6 | 6 | 0.01% | 0.15% | 0.22% | Q1 2015 | Q2 2016 | 6 |
BEAT | BIOTELEMETRY INC | 5 | 1 | 0.02% | 0.15% | 0.20% | Q4 2013 | Q3 2015 | 6 |
NEOGENOMICS INC | 6 | 6 | 0.11% | 0.12% | 0.14% | Q2 2022 | Q3 2023 | 6 | |
ACUR | ACURA PHARMACEUTICALS INC | 6 | 6 | 0.03% | 0.08% | 0.12% | Q3 2015 | Q4 2016 | 6 |
CORSICANTO LTD | 6 | 6 | 0.03% | 0.04% | 0.04% | Q1 2015 | Q2 2016 | 6 | |
EUCRW | EUCRATES BIOMEDICAL AC... | 6 | 6 | 0.00% | 0.00% | 0.00% | Q4 2021 | Q1 2023 | 6 |
ASPX | AUSPEX PHARMACEUTICALS... | 5 | 5 | 1.78% | 5.33% | 14.45% | Q1 2014 | Q1 2015 | 5 |
IONIS PHARMACEUTICALS INC | 5 | 5 | 2.41% | 2.52% | 2.60% | Q2 2022 | Q2 2023 | 5 | |
CPRX | CATALYST PHARMACEUTICA... | 5 | 5 | 1.25% | 2.36% | 3.83% | Q3 2022 | Q3 2023 | 5 |
HUM | HUMANA INC | 5 | 5 | 1.33% | 2.32% | 5.89% | Q4 2013 | Q4 2014 | 5 |
ENVISTA HOLDINGS CORPO... | 5 | 5 | 1.99% | 2.28% | 2.77% | Q2 2021 | Q2 2022 | 5 | |
INTERCEPT PHARMACEUTIC... | 5 | 5 | 1.61% | 2.03% | 2.32% | Q3 2022 | Q3 2023 | 5 | |
BRIDGEBIO PHARMA INC | 5 | 5 | 1.06% | 1.91% | 2.77% | Q1 2021 | Q1 2022 | 5 | |
AMAG PHARMACEUTICALS INC | 4 | 1 | 0.28% | 1.70% | 2.69% | Q1 2014 | Q2 2016 | 5 | |
HOLOGIC INC | 5 | 5 | 0.48% | 1.61% | 2.24% | Q2 2013 | Q2 2014 | 5 | |
QCOR | QUESTCOR PHARMACEUTICA... | 5 | 5 | 0.02% | 1.54% | 4.25% | Q2 2013 | Q2 2014 | 5 |
INTERMUNE INC | 5 | 5 | 0.29% | 1.53% | 2.10% | Q2 2013 | Q2 2014 | 5 | |
WRIGHT MED GROUP INC | 5 | 5 | 0.92% | 1.52% | 1.99% | Q1 2016 | Q1 2017 | 5 | |
BIIB | BIOGEN INC | 2 | 1 | 0.06% | 1.19% | 2.17% | Q1 2014 | Q3 2022 | 5 |
NANOSTRING TECHNOLOGIE... | 5 | 5 | 0.97% | 1.16% | 1.29% | Q3 2022 | Q3 2023 | 5 | |
DPLO | DIPLOMAT PHARMACY INC | 5 | 5 | 0.59% | 1.11% | 1.57% | Q3 2018 | Q3 2019 | 5 |
ACHC | ACADIA HEALTHCARE COMP... | 5 | 5 | 0.64% | 1.09% | 1.80% | Q4 2017 | Q4 2018 | 5 |
AIRM | AIR METHODS CORP | 5 | 5 | 0.65% | 1.07% | 1.39% | Q2 2013 | Q2 2014 | 5 |
ARNA | ARENA PHARMACEUTICALS INC | 5 | 5 | 0.38% | 1.04% | 2.04% | Q2 2017 | Q2 2018 | 5 |
GMED | GLOBUS MED INC | 2 | 1 | 0.35% | 1.01% | 1.77% | Q3 2013 | Q1 2017 | 5 |
K2M GROUP HLDGS INC | 5 | 5 | 0.81% | 0.96% | 1.10% | Q3 2017 | Q3 2018 | 5 | |
ENHABIT INC | 5 | 5 | 0.41% | 0.94% | 1.24% | Q3 2022 | Q3 2023 | 5 | |
RLYP | RELYPSA INC | 5 | 5 | 0.25% | 0.87% | 1.21% | Q2 2015 | Q2 2016 | 5 |
THC | TENET HEALTHCARE CORP | 2 | 1 | 0.04% | 0.66% | 1.51% | Q2 2013 | Q3 2015 | 5 |
EOLS | EVOLUS INC | 5 | 5 | 0.31% | 0.65% | 0.87% | Q1 2022 | Q1 2023 | 5 |
HTWR | HEARTWARE INTL INC | 3 | 1 | 0.27% | 0.64% | 1.16% | Q2 2013 | Q1 2016 | 5 |
HOLX | HOLOGIC INC | 2 | 1 | 0.03% | 0.61% | 2.27% | Q2 2013 | Q3 2020 | 5 |
GI | ENDOCHOICE HLDGS INC | 5 | 5 | 0.23% | 0.60% | 0.98% | Q2 2015 | Q2 2016 | 5 |
FOLD | AMICUS THERAPEUTICS INC | 2 | 1 | 0.10% | 0.55% | 0.95% | Q3 2014 | Q2 2021 | 5 |
SPPI | SPECTRUM PHARMACEUTICA... | 5 | 5 | 0.01% | 0.55% | 1.18% | Q2 2013 | Q2 2014 | 5 |
AEGERION PHARMACEUTICA... | 5 | 5 | 0.38% | 0.53% | 0.72% | Q2 2017 | Q2 2018 | 5 | |
TSRO | TESARO INC | 3 | 2 | 0.08% | 0.47% | 1.13% | Q3 2016 | Q1 2018 | 5 |
CBAY | CYMABAY THERAPEUTICS INC | 4 | 1 | 0.13% | 0.45% | 0.63% | Q3 2014 | Q4 2018 | 5 |
AVRO | AVROBIO INC | 3 | 1 | 0.20% | 0.40% | 0.75% | Q2 2018 | Q4 2020 | 5 |
VIGIL NEUROSCIENCE INC | 5 | 5 | 0.22% | 0.39% | 0.53% | Q3 2022 | Q3 2023 | 5 | |
TARS | TARSUS PHARMACEUTICALS... | 4 | 1 | 0.30% | 0.37% | 0.45% | Q2 2022 | Q3 2023 | 5 |
RNA | AVIDITY BIOSCIENCES INC | 5 | 5 | 0.21% | 0.35% | 0.72% | Q2 2020 | Q2 2021 | 5 |
ELOS | SYNERON MEDICAL LTD | 3 | 1 | 0.01% | 0.31% | 0.70% | Q1 2014 | Q3 2015 | 5 |
AUXILIUM PHARMACEUTICA... | 5 | 5 | 0.07% | 0.31% | 1.07% | Q2 2013 | Q2 2014 | 5 | |
VKTX | VIKING THERAPEUTICS INC | 3 | 1 | 0.05% | 0.29% | 0.42% | Q3 2018 | Q3 2023 | 5 |
ALERE INC | 5 | 5 | 0.25% | 0.28% | 0.33% | Q2 2013 | Q2 2014 | 5 | |
SGMO | SANGAMO THERAPEUTICS INC | 4 | 1 | 0.02% | 0.25% | 0.51% | Q3 2014 | Q3 2017 | 5 |
APEN | APOLLO ENDOSURGERY INC | 5 | 5 | 0.13% | 0.25% | 0.36% | Q4 2021 | Q4 2022 | 5 |
IMRA | IMARA INC | 5 | 5 | 0.01% | 0.22% | 0.34% | Q1 2020 | Q1 2021 | 5 |
MTAC | MEDTECH ACQUISITION CORP | 5 | 5 | 0.19% | 0.20% | 0.22% | Q3 2021 | Q3 2022 | 5 |
SNRH | SENIOR CONNECT ACQUISI... | 5 | 5 | 0.19% | 0.20% | 0.22% | Q3 2021 | Q3 2022 | 5 |
REVH | REVOLUTION HEALTHCAR A... | 5 | 5 | 0.19% | 0.20% | 0.22% | Q3 2021 | Q3 2022 | 5 |
PRQR | PROQR THRAPEUTICS N V | 5 | 5 | 0.12% | 0.20% | 0.33% | Q3 2014 | Q3 2015 | 5 |
TXMD | THERAPEUTICSMD INC CO... | 2 | 1 | 0.02% | 0.18% | 0.44% | Q3 2013 | Q4 2019 | 5 |
IGI LABORATORIES INC | 5 | 5 | 0.06% | 0.17% | 0.37% | Q1 2018 | Q1 2019 | 5 | |
IGNY | IGNYTE ACQUISITION CORP | 5 | 5 | 0.14% | 0.15% | 0.16% | Q3 2021 | Q3 2022 | 5 |
EGLTQ | EGALET CORP | 4 | 1 | 0.03% | 0.15% | 0.24% | Q3 2015 | Q1 2018 | 5 |
ALDX | ALDEYRA THERAPEUTICS INC | 5 | 5 | 0.06% | 0.13% | 0.19% | Q2 2015 | Q2 2016 | 5 |
MRGE | MERGE HEALTHCARE INC | 4 | 1 | 0.10% | 0.13% | 0.16% | Q2 2013 | Q4 2014 | 5 |
OHPA | ORION ACQUISITION CORP | 5 | 5 | 0.10% | 0.10% | 0.11% | Q3 2021 | Q3 2022 | 5 |
POZN | POZEN INC | 3 | 2 | 0.01% | 0.09% | 0.22% | Q2 2014 | Q4 2015 | 5 |
OBLN | OBALON THERAPEUTICS INC | 5 | 5 | 0.01% | 0.09% | 0.15% | Q1 2017 | Q1 2018 | 5 |
MTCR | METACRINE INC | 5 | 5 | 0.02% | 0.07% | 0.23% | Q3 2020 | Q3 2021 | 5 |
ILMN | ILLUMINA INC | 2 | 1 | 0.03% | 0.06% | 0.11% | Q2 2013 | Q3 2015 | 5 |
NEOGENOMICS INC | 5 | 5 | 0.04% | 0.05% | 0.05% | Q1 2021 | Q1 2022 | 5 | |
IMRSQ | IMRIS INC | 4 | 1 | 0.00% | 0.01% | 0.02% | Q4 2013 | Q1 2015 | 5 |
IGNYW | IGNYTE ACQUISITION CORP | 5 | 5 | 0.00% | 0.00% | 0.01% | Q3 2021 | Q3 2022 | 5 |
REVHW | REVOLUTION HEALTHCAR A... | 5 | 5 | 0.00% | 0.00% | 0.00% | Q3 2021 | Q3 2022 | 5 |
OHPAW | ORION ACQUISITION CORP | 5 | 5 | 0.00% | 0.00% | 0.00% | Q3 2021 | Q3 2022 | 5 |
DFPHU | DFP HEALTHCARE ACQUISI... | 4 | 4 | 1.11% | 2.60% | 3.27% | Q1 2020 | Q4 2020 | 4 |
BROOKDALE SR LIVING INC | 4 | 4 | 2.32% | 2.41% | 2.52% | Q4 2022 | Q3 2023 | 4 | |
DEXCOM INC | 4 | 4 | 1.03% | 2.04% | 3.02% | Q3 2018 | Q2 2019 | 4 | |
EXELIXIS INC | 3 | 1 | 0.12% | 1.59% | 3.08% | Q2 2013 | Q1 2015 | 4 | |
SBTX | ARS PHARMACEUTICALS INC | 4 | 4 | 0.92% | 1.52% | 1.96% | Q4 2022 | Q3 2023 | 4 |
CVS | CVS HEALTH CORP | 4 | 4 | 1.22% | 1.40% | 1.60% | Q1 2018 | Q4 2018 | 4 |
CBST | CUBIST PHARMACEUTICALS... | 3 | 1 | 0.76% | 1.34% | 1.64% | Q2 2013 | Q4 2014 | 4 |
MRK | MERCK & CO INC NEW | 4 | 4 | 1.05% | 1.32% | 1.88% | Q2 2013 | Q1 2014 | 4 |
DFPH | DFP HEALTHCARE ACQUISI... | 4 | 4 | 0.88% | 1.30% | 2.19% | Q4 2020 | Q3 2021 | 4 |
CRL | CHARLES RIV LABS INTL INC | 4 | 4 | 0.74% | 1.21% | 1.43% | Q1 2015 | Q4 2015 | 4 |
PODD | INSULET CORP | 3 | 1 | 0.45% | 1.03% | 1.92% | Q3 2017 | Q3 2023 | 4 |
TEVA | TEVA PHARMACEUTICAL IN... | 2 | 2 | 0.62% | 1.00% | 1.46% | Q3 2013 | Q4 2015 | 4 |
IMGN | IMMUNOGEN INC | 4 | 4 | 0.37% | 0.93% | 1.39% | Q1 2022 | Q4 2022 | 4 |
APR | APRIA INC | 4 | 4 | 0.70% | 0.91% | 1.13% | Q1 2021 | Q4 2021 | 4 |
1LIFE HEALTHCARE INC | 4 | 4 | 0.78% | 0.80% | 0.83% | Q1 2022 | Q4 2022 | 4 | |
WEBMD HEALTH CORP | 4 | 4 | 0.61% | 0.78% | 0.91% | Q4 2014 | Q3 2015 | 4 | |
SELB | SELECTA BIOSCIENCES INC | 4 | 4 | 0.58% | 0.77% | 1.12% | Q4 2016 | Q3 2017 | 4 |
EXACT SCIENCES CORP | 3 | 1 | 0.38% | 0.69% | 0.93% | Q1 2018 | Q2 2019 | 4 | |
TRIV | TRIVASCULAR TECHNOLOGI... | 4 | 4 | 0.34% | 0.65% | 0.93% | Q2 2014 | Q1 2015 | 4 |
DENDREON CORP | 4 | 4 | 0.58% | 0.64% | 0.74% | Q2 2013 | Q1 2014 | 4 | |
GH | GUARDANT HEALTH INC | 3 | 1 | 0.33% | 0.64% | 0.96% | Q3 2019 | Q3 2023 | 4 |
ICPT | INTERCEPT PHARMACEUTIC... | 2 | 2 | 0.34% | 0.63% | 0.85% | Q3 2014 | Q3 2023 | 4 |
ABMD | ABIOMED INC | 1 | 1 | 0.20% | 0.63% | 1.73% | Q3 2014 | Q1 2020 | 4 |
GBIO | GENERATION BIO CO | 4 | 4 | 0.54% | 0.63% | 0.72% | Q2 2020 | Q1 2021 | 4 |
AAAP | ADVANCED ACCELERATOR A... | 4 | 4 | 0.23% | 0.63% | 0.82% | Q4 2016 | Q3 2017 | 4 |
NUVA | NUVASIVE INC | 3 | 1 | 0.50% | 0.58% | 0.71% | Q1 2015 | Q4 2020 | 4 |
AIMT | AIMMUNE THERAPEUTICS INC | 3 | 1 | 0.29% | 0.56% | 0.78% | Q1 2018 | Q3 2019 | 4 |
INTERMUNE INC | 4 | 4 | 0.38% | 0.55% | 0.80% | Q2 2013 | Q1 2014 | 4 | |
KITE | KITE PHARMA INC | 2 | 2 | 0.24% | 0.54% | 1.05% | Q3 2014 | Q1 2017 | 4 |
MLNT | MELINTA THERAPEUTICS INC | 4 | 4 | 0.01% | 0.51% | 0.89% | Q1 2018 | Q4 2018 | 4 |
HCA | HCA HOLDINGS INC | 2 | 1 | 0.02% | 0.50% | 0.94% | Q2 2013 | Q3 2014 | 4 |
ZGNX | ZOGENIX INC | 4 | 4 | 0.31% | 0.47% | 0.72% | Q2 2013 | Q1 2014 | 4 |
STJ | ST JUDE MED INC | 2 | 1 | 0.11% | 0.47% | 1.13% | Q2 2013 | Q3 2016 | 4 |
MYOV | MYOVANT SCIENCES LTD | 4 | 4 | 0.25% | 0.40% | 0.77% | Q4 2016 | Q3 2017 | 4 |
AMPH | AMPHASTAR PHARMACEUTIC... | 4 | 4 | 0.22% | 0.40% | 0.60% | Q3 2014 | Q2 2015 | 4 |
INSP | INSPIRE MED SYS INC | 4 | 4 | 0.28% | 0.40% | 0.68% | Q3 2018 | Q2 2019 | 4 |
FTSV | FORTY SEVEN INC | 3 | 1 | 0.20% | 0.39% | 0.56% | Q2 2018 | Q1 2020 | 4 |
DNLI | DENALI THERAPEUTICS INC | 4 | 4 | 0.27% | 0.35% | 0.46% | Q4 2022 | Q3 2023 | 4 |
ATNX | ATHENEX INC | 3 | 1 | 0.29% | 0.35% | 0.44% | Q4 2018 | Q3 2020 | 4 |
NSPH | NANOSPHERE INC | 4 | 4 | 0.13% | 0.34% | 0.56% | Q3 2013 | Q2 2014 | 4 |
GENN | GENESIS HEALTHCARE INC | 4 | 4 | 0.14% | 0.32% | 0.47% | Q1 2015 | Q4 2015 | 4 |
ACCURAY INC | 4 | 4 | 0.27% | 0.32% | 0.39% | Q1 2014 | Q4 2014 | 4 | |
CGEM | CULLINAN ONCOLOGY INC | 4 | 4 | 0.09% | 0.31% | 0.48% | Q2 2021 | Q1 2022 | 4 |
JAZZ INVESTMENTS I LTD | 3 | 1 | 0.20% | 0.31% | 0.61% | Q3 2015 | Q1 2020 | 4 | |
OLMA | OLEMA PHARMACEUTICALS INC | 4 | 4 | 0.14% | 0.28% | 0.66% | Q4 2020 | Q3 2021 | 4 |
PRTA | PROTHENA CORP PLC | 2 | 1 | 0.02% | 0.27% | 0.73% | Q4 2013 | Q2 2018 | 4 |
AUTL | AUTOLUS THERAPEUTICS PLC | 3 | 1 | 0.24% | 0.27% | 0.31% | Q2 2018 | Q1 2021 | 4 |
PRIME MEDICINE INC | 4 | 4 | 0.19% | 0.26% | 0.34% | Q4 2022 | Q3 2023 | 4 | |
DYN | DYNE THERAPEUTICS INC | 4 | 4 | 0.20% | 0.24% | 0.29% | Q3 2020 | Q2 2021 | 4 |
KBIO | KALOBIOS PHARMACEUTICA... | 4 | 4 | 0.14% | 0.22% | 0.31% | Q1 2014 | Q4 2014 | 4 |
SRSA | SARISSA CAPITAL ACQUIS... | 4 | 4 | 0.20% | 0.21% | 0.22% | Q4 2021 | Q3 2022 | 4 |
EUCR | EUCRATES BIOMEDICAL AC... | 4 | 4 | 0.20% | 0.21% | 0.22% | Q4 2021 | Q3 2022 | 4 |
FDMT | 4D MOLECULAR THERAPEUT... | 2 | 2 | 0.12% | 0.17% | 0.25% | Q4 2020 | Q3 2023 | 4 |
CSTL | CASTLE BIOSCIENCES INC | 2 | 1 | 0.07% | 0.17% | 0.35% | Q3 2019 | Q3 2023 | 4 |
ALQA | ALLIQUA BIOMEDICAL INC | 4 | 4 | 0.02% | 0.17% | 0.30% | Q2 2015 | Q1 2016 | 4 |
LMNS | LUMENIS LTD | 4 | 4 | 0.12% | 0.17% | 0.20% | Q2 2014 | Q1 2015 | 4 |
MNLO | MENLO THERAPEUTICS INC | 3 | 1 | 0.02% | 0.17% | 0.56% | Q1 2018 | Q3 2019 | 4 |
AGLE | AEGLEA BIOTHERAPEUTICS... | 3 | 1 | 0.12% | 0.16% | 0.22% | Q1 2019 | Q2 2020 | 4 |
TMPM | TURMERIC ACQUISITION CORP | 4 | 4 | 0.15% | 0.16% | 0.16% | Q4 2021 | Q3 2022 | 4 |
ESPR | ESPERION THERAPEUTICS ... | 3 | 1 | 0.01% | 0.15% | 0.52% | Q1 2015 | Q4 2021 | 4 |
EGRX | EAGLE PHARMACEUTICALS INC | 4 | 4 | 0.13% | 0.15% | 0.16% | Q1 2014 | Q4 2014 | 4 |
TMPMU | TURMERIC ACQUISITION CORP | 4 | 4 | 0.13% | 0.15% | 0.16% | Q4 2020 | Q3 2021 | 4 |
BENEFITFOCUS INC | 3 | 1 | 0.11% | 0.12% | 0.12% | Q1 2021 | Q2 2022 | 4 | |
MNKD | MANNKIND CORP | 2 | 1 | 0.04% | 0.11% | 0.20% | Q2 2017 | Q4 2018 | 4 |
HARP | HARPOON THERAPEUTICS INC | 3 | 1 | 0.06% | 0.11% | 0.15% | Q1 2019 | Q1 2020 | 4 |
VCYT | VERACYTE INC | 4 | 4 | 0.04% | 0.09% | 0.14% | Q2 2015 | Q1 2016 | 4 |
CDTX | CIDARA THERAPEUTICS INC | 4 | 4 | 0.04% | 0.09% | 0.12% | Q2 2015 | Q1 2016 | 4 |
EXEL | EXELIXIS INC | 4 | 4 | 0.05% | 0.08% | 0.14% | Q1 2014 | Q4 2014 | 4 |
PTI | PROTEOSTASIS THERAPEUT... | 2 | 1 | 0.00% | 0.07% | 0.14% | Q3 2016 | Q4 2018 | 4 |
BVX | BOVIE MEDICAL CORP | 4 | 4 | 0.05% | 0.06% | 0.06% | Q1 2015 | Q4 2015 | 4 |
THLD | THRESHOLD PHARMACEUTIC... | 4 | 4 | 0.04% | 0.06% | 0.07% | Q2 2016 | Q1 2017 | 4 |
MSTX | MAST THERAPEUTICS INC | 3 | 1 | 0.01% | 0.05% | 0.08% | Q2 2013 | Q4 2014 | 4 |
KND | KINDRED HEALTHCARE INC | 2 | 2 | 0.02% | 0.05% | 0.07% | Q3 2014 | Q3 2015 | 4 |
ALKS | ALKERMES PLC | 2 | 1 | 0.01% | 0.04% | 0.09% | Q2 2013 | Q1 2015 | 4 |
OREX | OREXIGEN THERAPEUTICS INC | 3 | 1 | 0.01% | 0.01% | 0.01% | Q2 2013 | Q2 2014 | 4 |
NEWAMSTERDAM PHARMA CO... | 4 | 4 | 0.00% | 0.00% | 0.00% | Q4 2022 | Q3 2023 | 4 | |
TMPMW | TURMERIC ACQUISITION CORP | 4 | 4 | 0.00% | 0.00% | 0.00% | Q4 2021 | Q3 2022 | 4 |
CBST | CUBIST PHARMACEUTICALS... | 3 | 3 | 3.41% | 3.81% | 4.43% | Q2 2013 | Q4 2013 | 3 |
AAVL | AVALANCHE BIOTECHNOLOG... | 3 | 3 | 2.55% | 2.82% | 3.13% | Q3 2014 | Q1 2015 | 3 |
SAREPTA THERAPEUTICS INC | 2 | 1 | 2.30% | 2.78% | 3.42% | Q1 2022 | Q4 2022 | 3 | |
NUVASIVE INC | 3 | 3 | 2.36% | 2.71% | 2.90% | Q2 2013 | Q4 2013 | 3 | |
DRNA | DICERNA PHARMACEUTICAL... | 3 | 3 | 1.13% | 2.04% | 2.80% | Q1 2014 | Q3 2014 | 3 |
PFE | PFIZER INC | 2 | 1 | 0.03% | 1.63% | 2.45% | Q2 2013 | Q1 2016 | 3 |
AZN | ASTRAZENECA PLC | 2 | 1 | 0.04% | 1.45% | 2.24% | Q2 2013 | Q2 2014 | 3 |
QCOR | QUESTCOR PHARMACEUTICA... | 3 | 3 | 0.93% | 1.44% | 1.99% | Q4 2013 | Q2 2014 | 3 |
ALXN | ALEXION PHARMACEUTICAL... | 2 | 1 | 0.61% | 1.36% | 1.86% | Q2 2020 | Q1 2021 | 3 |
AMYLYX PHARMACEUTICALS... | 3 | 3 | 0.48% | 1.28% | 2.06% | Q4 2022 | Q2 2023 | 3 | |
BROOKDALE SR LIVING INC | 3 | 3 | 0.96% | 1.24% | 1.39% | Q2 2013 | Q4 2013 | 3 | |
NKTX | NKARTA INC | 2 | 1 | 0.15% | 1.22% | 1.77% | Q3 2020 | Q2 2022 | 3 |
GHDX | GENOMIC HEALTH INC | 3 | 3 | 0.90% | 1.05% | 1.16% | Q2 2015 | Q4 2015 | 3 |
CSU | CAPITAL SR LIVING CORP | 3 | 3 | 0.33% | 1.04% | 1.76% | Q3 2013 | Q1 2014 | 3 |
HZNP | HORIZON PHARMA INC | 3 | 3 | 0.39% | 1.01% | 1.83% | Q4 2013 | Q2 2014 | 3 |
ANGO | ANGIODYNAMICS INC | 2 | 1 | 0.34% | 1.00% | 1.41% | Q2 2013 | Q3 2014 | 3 |
XOMA | XOMA CORP DEL | 3 | 3 | 0.20% | 0.94% | 1.33% | Q2 2013 | Q4 2013 | 3 |
MOLINA HEALTHCARE INC | 3 | 3 | 0.17% | 0.92% | 1.43% | Q3 2016 | Q1 2017 | 3 | |
DEPOMED INC | 3 | 3 | 0.76% | 0.81% | 0.90% | Q4 2017 | Q2 2018 | 3 | |
QDEL | QUIDEL CORP | 2 | 1 | 0.70% | 0.80% | 0.93% | Q3 2020 | Q2 2021 | 3 |
CAH | CARDINAL HEALTH INC | 2 | 1 | 0.02% | 0.79% | 1.56% | Q2 2013 | Q3 2015 | 3 |
ACOR | ACORDA THERAPEUTICS INC | 3 | 3 | 0.16% | 0.78% | 1.16% | Q1 2016 | Q3 2016 | 3 |
MYL | MYLAN INC | 3 | 3 | 0.04% | 0.76% | 1.38% | Q3 2013 | Q1 2014 | 3 |
OAK STR HEALTH INC | 2 | 1 | 0.32% | 0.74% | 1.57% | Q1 2022 | Q1 2023 | 3 | |
PHR | PHREESIA INC | 3 | 3 | 0.44% | 0.68% | 0.92% | Q2 2022 | Q4 2022 | 3 |
CI | CIGNA CORPORATION | 2 | 1 | 0.55% | 0.66% | 0.86% | Q2 2014 | Q2 2016 | 3 |
THOR | THORATEC CORP | 2 | 1 | 0.12% | 0.66% | 1.54% | Q3 2013 | Q4 2014 | 3 |
NEWAMSTERDAM PHARMA CO... | 3 | 3 | 0.56% | 0.65% | 0.75% | Q4 2022 | Q2 2023 | 3 | |
ANIP | ANI PHARMACEUTICALS INC | 3 | 3 | 0.48% | 0.65% | 0.84% | Q1 2014 | Q3 2014 | 3 |
MDT | MEDTRONIC INC | 3 | 3 | 0.14% | 0.59% | 1.17% | Q1 2014 | Q3 2014 | 3 |
KOD | KODIAK SCIENCES INC | 2 | 1 | 0.46% | 0.59% | 0.72% | Q4 2019 | Q4 2020 | 3 |
DOCGO INC | 3 | 3 | 0.56% | 0.59% | 0.61% | Q1 2023 | Q3 2023 | 3 | |
PACIRA BIOSCIENCES INC | 2 | 1 | 0.45% | 0.56% | 0.64% | Q1 2020 | Q4 2020 | 3 | |
DEPO | DEPOMED INC | 3 | 3 | 0.40% | 0.54% | 0.69% | Q2 2013 | Q4 2013 | 3 |
EW | EDWARDS LIFESCIENCES CORP | 2 | 1 | 0.05% | 0.53% | 1.00% | Q4 2014 | Q3 2015 | 3 |
MGNX | MACROGENICS INC | 3 | 3 | 0.41% | 0.51% | 0.65% | Q3 2015 | Q1 2016 | 3 |
GTHX | G1 THERAPEUTICS INC | 3 | 3 | 0.44% | 0.48% | 0.54% | Q1 2018 | Q3 2018 | 3 |
STRUCTURE THERAPEUTICS... | 3 | 3 | 0.20% | 0.48% | 0.70% | Q1 2023 | Q3 2023 | 3 | |
APLS | APELLIS PHARMACEUTICAL... | 1 | 1 | 0.34% | 0.46% | 0.61% | Q4 2017 | Q2 2023 | 3 |
TIL | INSTIL BIO INC | 3 | 3 | 0.38% | 0.45% | 0.59% | Q1 2021 | Q3 2021 | 3 |
JUNO | JUNO THERAPEUTICS INC | 3 | 3 | 0.32% | 0.45% | 0.67% | Q4 2014 | Q2 2015 | 3 |
VAPO | VAPOTHERM INC | 2 | 1 | 0.32% | 0.42% | 0.62% | Q1 2020 | Q4 2020 | 3 |
CEMP | CEMPRA INC | 3 | 3 | 0.20% | 0.41% | 0.59% | Q2 2013 | Q4 2013 | 3 |
XILIO THERAPEUTICS INC | 3 | 3 | 0.12% | 0.39% | 0.71% | Q4 2021 | Q2 2022 | 3 | |
ADCT | ADC THERAPEUTICS SA | 2 | 1 | 0.23% | 0.38% | 0.68% | Q2 2020 | Q3 2022 | 3 |
SWAV | SHOCKWAVE MED INC | 2 | 1 | 0.10% | 0.38% | 0.64% | Q1 2019 | Q4 2019 | 3 |
ITCI | INTRA-CELLULAR THERAPI... | 1 | 1 | 0.08% | 0.37% | 0.89% | Q1 2014 | Q1 2023 | 3 |
ACCURAY INC | 3 | 3 | 0.30% | 0.36% | 0.45% | Q2 2013 | Q4 2013 | 3 | |
KRYS | KRYSTAL BIOTECH INC | 3 | 3 | 0.24% | 0.36% | 0.56% | Q3 2022 | Q1 2023 | 3 |
CLVS | CLOVIS ONCOLOGY INC | 2 | 1 | 0.01% | 0.36% | 0.97% | Q2 2013 | Q3 2016 | 3 |
TARA | PROTARA THERAPEUTICS INC | 3 | 3 | 0.32% | 0.35% | 0.37% | Q2 2020 | Q4 2020 | 3 |
CMRX | CHIMERIX INC | 2 | 1 | 0.26% | 0.34% | 0.41% | Q3 2014 | Q2 2021 | 3 |
FMI | FOUNDATION MEDICINE INC | 3 | 3 | 0.15% | 0.34% | 0.45% | Q4 2013 | Q2 2014 | 3 |
ROIVANT SCIENCES LTD | 3 | 3 | 0.29% | 0.33% | 0.41% | Q1 2023 | Q3 2023 | 3 | |
BMRN | BIOMARIN PHARMACEUTICA... | 1 | 1 | 0.06% | 0.33% | 0.65% | Q2 2013 | Q4 2020 | 3 |
NVAX | NOVAVAX INC | 1 | 1 | 0.16% | 0.33% | 0.54% | Q3 2013 | Q1 2016 | 3 |
EXAS | EXACT SCIENCES CORP | 2 | 1 | 0.28% | 0.30% | 0.33% | Q3 2016 | Q4 2018 | 3 |
CCRN | CROSS CTRY HEALTHCARE INC | 2 | 1 | 0.14% | 0.30% | 0.38% | Q2 2013 | Q1 2015 | 3 |
ATRC | ATRICURE INC | 2 | 1 | 0.28% | 0.29% | 0.30% | Q2 2013 | Q4 2019 | 3 |
TGTX | TG THERAPEUTICS INC | 2 | 1 | 0.24% | 0.29% | 0.32% | Q1 2017 | Q3 2022 | 3 |
VINC | VINCERX PHARMA INC | 3 | 3 | 0.12% | 0.28% | 0.44% | Q3 2021 | Q1 2022 | 3 |
WMGI | WRIGHT MED GROUP N V | 2 | 1 | 0.02% | 0.26% | 0.44% | Q1 2016 | Q2 2018 | 3 |
CERS | CERUS CORP | 3 | 3 | 0.01% | 0.25% | 0.42% | Q1 2020 | Q3 2020 | 3 |
XFOR | X4 PHARMACEUTICALS INC | 3 | 3 | 0.15% | 0.25% | 0.30% | Q2 2019 | Q4 2019 | 3 |
CAPAU | HIGHCAPE CAP ACQUISITI... | 3 | 3 | 0.20% | 0.24% | 0.27% | Q3 2020 | Q1 2021 | 3 |
TTPH | TETRAPHASE PHARMACEUTI... | 2 | 1 | 0.17% | 0.23% | 0.33% | Q2 2013 | Q3 2014 | 3 |
BAX | BAXTER INTL INC | 3 | 3 | 0.05% | 0.22% | 0.37% | Q3 2013 | Q1 2014 | 3 |
VRTX | VERTEX PHARMACEUTICALS... | 2 | 1 | 0.08% | 0.22% | 0.35% | Q1 2014 | Q3 2015 | 3 |
SNRHU | SENIOR CONNECT ACQUISI... | 3 | 3 | 0.18% | 0.20% | 0.21% | Q4 2020 | Q2 2021 | 3 |
VSAR | VERSARTIS INC | 2 | 1 | 0.12% | 0.19% | 0.25% | Q1 2015 | Q4 2015 | 3 |
AN2 THERAPEUTICS INC | 3 | 3 | 0.12% | 0.19% | 0.25% | Q1 2022 | Q3 2022 | 3 | |
CGIX | CANCER GENETICS INC | 3 | 3 | 0.10% | 0.18% | 0.25% | Q4 2013 | Q2 2014 | 3 |
PRVA | PRIVIA HEALTH GROUP INC | 3 | 3 | 0.14% | 0.18% | 0.24% | Q2 2021 | Q4 2021 | 3 |
DERM | DERMIRA INC | 3 | 3 | 0.08% | 0.16% | 0.29% | Q4 2014 | Q2 2015 | 3 |
CARA | CARA THERAPEUTICS INC | 3 | 3 | 0.12% | 0.15% | 0.17% | Q3 2014 | Q1 2015 | 3 |
ALBO | ALBIREO PHARMA INC | 3 | 3 | 0.14% | 0.14% | 0.15% | Q1 2018 | Q3 2018 | 3 |
NVTRQ | NUVECTRA CORP | 3 | 3 | 0.08% | 0.13% | 0.22% | Q2 2018 | Q4 2018 | 3 |
LCAV | LCA-VISION INC | 3 | 3 | 0.12% | 0.13% | 0.15% | Q2 2013 | Q4 2013 | 3 |
BENEFITFOCUS INC | 2 | 1 | 0.11% | 0.13% | 0.14% | Q4 2020 | Q1 2022 | 3 | |
TRIB | TRINITY BIOTECH PLC | 3 | 3 | 0.11% | 0.13% | 0.16% | Q2 2015 | Q4 2015 | 3 |
PEPGEN INC | 3 | 3 | 0.02% | 0.12% | 0.20% | Q2 2022 | Q4 2022 | 3 | |
SNSS | SUNESIS PHARMACEUTICAL... | 3 | 3 | 0.06% | 0.10% | 0.13% | Q1 2014 | Q3 2014 | 3 |
CHFWU | CONSONANCE HFW ACQUISI... | 3 | 3 | 0.09% | 0.10% | 0.10% | Q4 2020 | Q2 2021 | 3 |
SVRA | SAVARA INC | 3 | 3 | 0.07% | 0.08% | 0.10% | Q3 2018 | Q1 2019 | 3 |
TLGT | TELIGENT INC NEW | 3 | 3 | 0.06% | 0.08% | 0.10% | Q1 2018 | Q3 2018 | 3 |
MZOR | MAZOR ROBOTICS LTD | 3 | 3 | 0.02% | 0.08% | 0.12% | Q1 2015 | Q3 2015 | 3 |
ONTY | ONCOTHYREON INC | 3 | 3 | 0.01% | 0.06% | 0.16% | Q3 2014 | Q1 2015 | 3 |
ABEONA THERAPEUTICS INC | 3 | 3 | 0.06% | 0.06% | 0.08% | Q4 2022 | Q2 2023 | 3 | |
PRTK | PARATEK PHARMACEUTICAL... | 3 | 3 | 0.06% | 0.06% | 0.06% | Q2 2016 | Q4 2016 | 3 |
PARNF | PARNELL PHARMACEUT HLD... | 3 | 3 | 0.04% | 0.06% | 0.08% | Q3 2014 | Q1 2015 | 3 |
ORCHARD THERAPEUTICS PLC | 3 | 3 | 0.04% | 0.04% | 0.05% | Q1 2023 | Q3 2023 | 3 | |
DFPHW | DFP HEALTHCARE ACQUISI... | 3 | 3 | 0.04% | 0.04% | 0.04% | Q1 2021 | Q3 2021 | 3 |
HMSY | HMS HLDGS CORP | 1 | 1 | 0.02% | 0.03% | 0.07% | Q4 2013 | Q1 2015 | 3 |
CEREW | CEREVEL THERAPEUTICS H... | 3 | 3 | 0.02% | 0.03% | 0.04% | Q4 2020 | Q2 2021 | 3 |
BONE | BACTERIN INTL HLDGS INC | 3 | 3 | 0.01% | 0.02% | 0.04% | Q2 2013 | Q4 2013 | 3 |
RNVA | RENNOVA HEALTH INC | 3 | 3 | 0.00% | 0.02% | 0.03% | Q4 2015 | Q2 2016 | 3 |
RENNOVA HEALTH INC | 3 | 3 | 0.00% | 0.01% | 0.01% | Q4 2015 | Q2 2016 | 3 | |
SRSAW | SARISSA CAPITAL ACQUIS... | 3 | 3 | 0.00% | 0.00% | 0.00% | Q1 2022 | Q3 2022 | 3 |
SIENTRA INC | 3 | 3 | 0.00% | 0.00% | 0.00% | Q1 2023 | Q3 2023 | 3 | |
NUVASIVE INC | 1 | 1 | 2.71% | 3.34% | 3.98% | Q2 2020 | Q4 2020 | 2 | |
ITMN | INTERMUNE INC | 2 | 2 | 2.16% | 3.14% | 4.11% | Q1 2014 | Q2 2014 | 2 |
HORIZON PHARMA INC | 2 | 2 | 2.53% | 2.75% | 2.96% | Q4 2014 | Q1 2015 | 2 | |
SDGR | SCHRODINGER INC | 2 | 2 | 1.84% | 2.72% | 3.59% | Q1 2020 | Q2 2020 | 2 |
GILD | GILEAD SCIENCES INC | 1 | 1 | 2.18% | 2.51% | 2.83% | Q4 2015 | Q2 2017 | 2 |
DEXCOM INC | 1 | 1 | 1.61% | 2.03% | 2.46% | Q4 2019 | Q2 2020 | 2 | |
DEXCOM INC | 1 | 1 | 1.87% | 1.98% | 2.09% | Q1 2020 | Q3 2020 | 2 | |
HCA | HCA HOLDINGS INC | 2 | 2 | 1.70% | 1.81% | 1.93% | Q2 2014 | Q3 2014 | 2 |
LH | LABORATORY CORP AMER H... | 2 | 2 | 0.62% | 1.74% | 2.85% | Q1 2014 | Q2 2014 | 2 |
FRX | FOREST LABS INC | 2 | 2 | 1.48% | 1.65% | 1.83% | Q2 2013 | Q3 2013 | 2 |
BSX | BOSTON SCIENTIFIC CORP | 1 | 1 | 0.83% | 1.58% | 2.32% | Q2 2015 | Q1 2021 | 2 |
TESARO INC | 2 | 2 | 1.22% | 1.56% | 1.89% | Q3 2014 | Q4 2014 | 2 | |
INSMED INC | 1 | 1 | 1.37% | 1.55% | 1.73% | Q2 2020 | Q4 2020 | 2 | |
THC | TENET HEALTHCARE CORP | 2 | 2 | 1.42% | 1.52% | 1.62% | Q2 2014 | Q3 2014 | 2 |
SGNT | SAGENT PHARMACEUTICALS... | 2 | 2 | 0.96% | 1.51% | 2.06% | Q2 2013 | Q3 2013 | 2 |
DFHT | DEERFIELD HEALTHCARE T... | 2 | 2 | 1.05% | 1.39% | 1.73% | Q4 2020 | Q1 2021 | 2 |
CYH | COMMUNITY HEALTH SYS I... | 2 | 2 | 1.37% | 1.39% | 1.41% | Q2 2013 | Q3 2013 | 2 |
CI | CIGNA CORPORATION | 2 | 2 | 1.24% | 1.31% | 1.39% | Q2 2014 | Q3 2014 | 2 |
CHRS | COHERUS BIOSCIENCES INC | 2 | 2 | 1.27% | 1.30% | 1.33% | Q2 2019 | Q3 2019 | 2 |
ALPHATEC HLDGS INC | 2 | 2 | 0.90% | 1.26% | 1.62% | Q3 2022 | Q4 2022 | 2 | |
CVS | CVS HEALTH CORP | 2 | 2 | 1.18% | 1.21% | 1.24% | Q1 2018 | Q2 2018 | 2 |
OSH | OAK STR HEALTH INC | 2 | 2 | 1.15% | 1.19% | 1.24% | Q3 2020 | Q4 2020 | 2 |
MNTA | MOMENTA PHARMACEUTICAL... | 2 | 2 | 1.04% | 1.19% | 1.34% | Q3 2013 | Q4 2013 | 2 |
AET | AETNA INC NEW | 2 | 2 | 1.11% | 1.16% | 1.22% | Q2 2014 | Q3 2014 | 2 |
ARIA | ARIAD PHARMACEUTICALS INC | 2 | 2 | 1.04% | 1.05% | 1.05% | Q2 2013 | Q3 2013 | 2 |
INSMED INC | 2 | 2 | 0.99% | 1.03% | 1.08% | Q2 2021 | Q3 2021 | 2 | |
OAK STR HEALTH INC | 2 | 2 | 1.00% | 1.02% | 1.04% | Q2 2022 | Q3 2022 | 2 | |
PDCO | PATTERSON COMPANIES INC | 2 | 2 | 0.98% | 0.98% | 0.98% | Q2 2017 | Q3 2017 | 2 |
DFHTU | DEERFIELD HEALTHCARE T... | 2 | 2 | 0.87% | 0.93% | 1.00% | Q3 2020 | Q4 2020 | 2 |
PCYC | PHARMACYCLICS INC | 2 | 2 | 0.82% | 0.83% | 0.85% | Q2 2013 | Q3 2013 | 2 |
NKTR | NEKTAR THERAPEUTICS | 1 | 1 | 0.02% | 0.81% | 1.60% | Q2 2013 | Q1 2015 | 2 |
AMAG PHARMACEUTICALS INC | 2 | 2 | 0.71% | 0.78% | 0.86% | Q3 2017 | Q4 2017 | 2 | |
ITMN | INTERMUNE INC | 2 | 2 | 0.13% | 0.75% | 1.37% | Q1 2014 | Q2 2014 | 2 |
RADIUS HEALTH INC | 2 | 2 | 0.68% | 0.71% | 0.73% | Q1 2018 | Q2 2018 | 2 | |
MYL | MYLAN N V | 2 | 2 | 0.68% | 0.69% | 0.71% | Q4 2016 | Q1 2017 | 2 |
FREQ | FREQUENCY THERAPEUTICS... | 2 | 2 | 0.54% | 0.66% | 0.79% | Q4 2019 | Q1 2020 | 2 |
GILD | GILEAD SCIENCES INC | 2 | 2 | 0.64% | 0.66% | 0.68% | Q4 2014 | Q1 2015 | 2 |
EW | EDWARDS LIFESCIENCES CORP | 2 | 2 | 0.63% | 0.64% | 0.65% | Q2 2013 | Q3 2013 | 2 |
AMAG | AMAG PHARMACEUTICALS INC | 2 | 2 | 0.42% | 0.63% | 0.83% | Q1 2014 | Q2 2014 | 2 |
ZTS | ZOETIS INC | 2 | 2 | 0.59% | 0.62% | 0.65% | Q1 2014 | Q2 2014 | 2 |
CSII | CARDIOVASCULAR SYS INC... | 1 | 1 | 0.60% | 0.62% | 0.63% | Q4 2015 | Q2 2020 | 2 |
GEVA | SYNAGEVA BIOPHARMA CORP | 1 | 1 | 0.15% | 0.61% | 1.08% | Q3 2013 | Q1 2014 | 2 |
LGVWU | LONGVIEW ACQUISITION CORP | 2 | 2 | 0.54% | 0.60% | 0.65% | Q2 2020 | Q3 2020 | 2 |
SHC | SOTERA HEALTH CO | 2 | 2 | 0.58% | 0.59% | 0.60% | Q4 2020 | Q1 2021 | 2 |
ACCD | ACCOLADE INC | 2 | 2 | 0.55% | 0.57% | 0.59% | Q3 2020 | Q4 2020 | 2 |
PETX | ARATANA THERAPEUTICS INC | 2 | 2 | 0.50% | 0.55% | 0.60% | Q1 2014 | Q2 2014 | 2 |
OSUR | ORASURE TECHNOLOGIES INC | 2 | 2 | 0.44% | 0.54% | 0.64% | Q3 2020 | Q4 2020 | 2 |
SEQUENOM INC | 2 | 2 | 0.30% | 0.53% | 0.75% | Q4 2013 | Q1 2014 | 2 | |
AGN | ALLERGAN PLC | 1 | 1 | 0.04% | 0.50% | 0.96% | Q1 2016 | Q4 2018 | 2 |
ACAD | ACADIA PHARMACEUTICALS... | 1 | 1 | 0.05% | 0.48% | 0.91% | Q2 2013 | Q1 2015 | 2 |
PCVX | VAXCYTE INC | 2 | 2 | 0.25% | 0.47% | 0.70% | Q4 2022 | Q1 2023 | 2 |
SLQT | SELECTQUOTE INC | 2 | 2 | 0.37% | 0.46% | 0.55% | Q2 2020 | Q3 2020 | 2 |
VENTYX BIOSCIENCES INC | 2 | 2 | 0.43% | 0.45% | 0.46% | Q1 2023 | Q2 2023 | 2 | |
ARAY | ACCURAY INC | 1 | 1 | 0.38% | 0.45% | 0.51% | Q2 2013 | Q4 2014 | 2 |
DISC MEDICINE INC | 2 | 2 | 0.41% | 0.43% | 0.44% | Q2 2023 | Q3 2023 | 2 | |
MAACU | MONTES ARCHIMEDES ACQU... | 2 | 2 | 0.42% | 0.42% | 0.43% | Q4 2020 | Q1 2021 | 2 |
EXEL | EXELIXIS INC | 2 | 2 | 0.33% | 0.42% | 0.50% | Q1 2015 | Q2 2015 | 2 |
GRPH | GRAPHITE BIO INC | 2 | 2 | 0.29% | 0.39% | 0.50% | Q2 2021 | Q3 2021 | 2 |
CERT | CERTARA INC | 2 | 2 | 0.34% | 0.37% | 0.40% | Q4 2020 | Q1 2021 | 2 |
PHAT | PHATHOM PHARMACEUTICAL... | 1 | 1 | 0.20% | 0.37% | 0.53% | Q3 2022 | Q2 2023 | 2 |
ALLO | ALLOGENE THERAPEUTICS INC | 2 | 2 | 0.35% | 0.36% | 0.36% | Q4 2018 | Q1 2019 | 2 |
AKRXQ | AKORN INC | 2 | 2 | 0.18% | 0.34% | 0.50% | Q2 2015 | Q3 2015 | 2 |
SPRB | SPRUCE BIOSCIENCES INC | 2 | 2 | 0.26% | 0.33% | 0.41% | Q2 2021 | Q3 2021 | 2 |
VRX | VALEANT PHARMACEUTICAL... | 1 | 1 | 0.01% | 0.32% | 0.64% | Q3 2015 | Q1 2017 | 2 |
ALHC | ALIGNMENT HEALTHCARE INC | 2 | 2 | 0.23% | 0.32% | 0.42% | Q2 2023 | Q3 2023 | 2 |
AIRM | AIR METHODS CORP | 2 | 2 | 0.25% | 0.31% | 0.38% | Q3 2013 | Q4 2013 | 2 |
MYL | MYLAN INC | 2 | 2 | 0.27% | 0.30% | 0.34% | Q3 2013 | Q4 2013 | 2 |
AVAH | AVEANNA HEALTHCARE HLD... | 2 | 2 | 0.16% | 0.30% | 0.44% | Q2 2021 | Q3 2021 | 2 |
CNCE | CONCERT PHARMACEUTICAL... | 2 | 2 | 0.25% | 0.30% | 0.34% | Q1 2014 | Q2 2014 | 2 |
SYK | STRYKER CORPORATION | 2 | 2 | 0.29% | 0.29% | 0.30% | Q4 2020 | Q1 2021 | 2 |
JNCE | JOUNCE THERAPEUTICS INC | 2 | 2 | 0.19% | 0.29% | 0.40% | Q1 2017 | Q2 2017 | 2 |
AVTE | AEROVATE THERAPEUTICS INC | 2 | 2 | 0.29% | 0.29% | 0.29% | Q2 2021 | Q3 2021 | 2 |
APLT | APPLIED THERAPEUTICS INC | 2 | 2 | 0.29% | 0.29% | 0.29% | Q1 2020 | Q2 2020 | 2 |
DNDNQ | DENDREON CORP | 2 | 2 | 0.10% | 0.29% | 0.48% | Q2 2013 | Q3 2013 | 2 |
LIVN | LIVANOVA PLC | 2 | 2 | 0.26% | 0.29% | 0.32% | Q3 2018 | Q4 2018 | 2 |
MCK | MCKESSON CORP | 2 | 2 | 0.26% | 0.28% | 0.30% | Q3 2017 | Q4 2017 | 2 |
MINERALYS THERAPEUTICS... | 2 | 2 | 0.26% | 0.28% | 0.30% | Q1 2023 | Q2 2023 | 2 | |
BVS | BIOVENTUS INC | 2 | 2 | 0.24% | 0.28% | 0.31% | Q1 2021 | Q2 2021 | 2 |
QURE | UNIQURE NV | 1 | 1 | 0.22% | 0.27% | 0.32% | Q1 2014 | Q3 2018 | 2 |
BBIO | BRIDGEBIO PHARMA INC | 2 | 2 | 0.25% | 0.27% | 0.28% | Q2 2019 | Q3 2019 | 2 |
VERASTEM INC | 2 | 2 | 0.24% | 0.26% | 0.28% | Q2 2023 | Q3 2023 | 2 | |
RAIN | RAIN ONCOLOGY INC | 2 | 2 | 0.04% | 0.25% | 0.46% | Q4 2022 | Q1 2023 | 2 |
OSMT | OSMOTICA PHARMACEUTICA... | 2 | 2 | 0.12% | 0.24% | 0.35% | Q4 2018 | Q1 2019 | 2 |
KPTI | KARYOPHARM THERAPEUTIC... | 2 | 2 | 0.18% | 0.23% | 0.29% | Q3 2018 | Q4 2018 | 2 |
LIFE | ATYR PHARMA INC | 2 | 2 | 0.18% | 0.23% | 0.28% | Q2 2015 | Q3 2015 | 2 |
SNDX | SYNDAX PHARMACEUTICALS... | 1 | 1 | 0.02% | 0.23% | 0.44% | Q1 2017 | Q2 2022 | 2 |
KZR | KEZAR LIFE SCIENCES INC | 1 | 1 | 0.21% | 0.22% | 0.24% | Q2 2022 | Q4 2022 | 2 |
ZSPH | ZS PHARMA INC | 2 | 2 | 0.20% | 0.22% | 0.23% | Q1 2015 | Q2 2015 | 2 |
IMCR | IMMUNOCORE HLDGS PLC | 2 | 2 | 0.15% | 0.20% | 0.25% | Q1 2021 | Q2 2021 | 2 |
BSTC | BIOSPECIFICS TECHNOLOG... | 2 | 2 | 0.18% | 0.20% | 0.22% | Q2 2014 | Q3 2014 | 2 |
FRX | FOREST LABS INC | 2 | 2 | 0.19% | 0.20% | 0.20% | Q2 2013 | Q3 2013 | 2 |
MDRX | ALLSCRIPTS HEALTHCARE ... | 1 | 1 | 0.01% | 0.20% | 0.38% | Q2 2013 | Q2 2014 | 2 |
REVHU | REVOLUTION HEALTHCAR A... | 2 | 2 | 0.18% | 0.20% | 0.21% | Q1 2021 | Q2 2021 | 2 |
GHRS | GH RESEARCH PLC | 2 | 2 | 0.18% | 0.19% | 0.21% | Q2 2021 | Q3 2021 | 2 |
NCNA | NUCANA PLC | 2 | 2 | 0.03% | 0.19% | 0.35% | Q3 2017 | Q4 2017 | 2 |
EIDX | EIDOS THERAPEUTICS INC | 2 | 2 | 0.15% | 0.19% | 0.23% | Q2 2018 | Q3 2018 | 2 |
DRTX | DURATA THERAPEUTICS INC | 2 | 2 | 0.12% | 0.19% | 0.26% | Q2 2013 | Q3 2013 | 2 |
DEFINITIVE HEALTHCARE ... | 2 | 2 | 0.14% | 0.18% | 0.21% | Q3 2021 | Q4 2021 | 2 | |
CYBX | CYBERONICS INC | 2 | 2 | 0.14% | 0.17% | 0.20% | Q2 2014 | Q3 2014 | 2 |
MDCO | MEDICINES CO | 2 | 2 | 0.13% | 0.17% | 0.20% | Q2 2019 | Q3 2019 | 2 |
CVRX | CVRX INC | 2 | 2 | 0.13% | 0.17% | 0.20% | Q2 2021 | Q3 2021 | 2 |
ACHL | ACHILLES THERAPEUTICS PLC | 2 | 2 | 0.05% | 0.16% | 0.28% | Q1 2021 | Q2 2021 | 2 |
CMIIU | CM LIFE SCIENCES II INC | 2 | 2 | 0.14% | 0.15% | 0.16% | Q1 2021 | Q2 2021 | 2 |
ARYBU | ARYA SCIENCES ACQUISTI... | 2 | 2 | 0.13% | 0.15% | 0.17% | Q2 2020 | Q3 2020 | 2 |
BINDQ | BIND THERAPEUTICS INC | 1 | 1 | 0.09% | 0.14% | 0.20% | Q4 2013 | Q3 2014 | 2 |
IGNYU | IGNYTE ACQUISITION CORP | 2 | 2 | 0.13% | 0.14% | 0.15% | Q1 2021 | Q2 2021 | 2 |
PANAU | PANACEA ACQUISITION CORP | 2 | 2 | 0.13% | 0.14% | 0.15% | Q3 2020 | Q4 2020 | 2 |
TSHA | TAYSHA GENE THERAPIES INC | 2 | 2 | 0.13% | 0.13% | 0.14% | Q3 2020 | Q4 2020 | 2 |
RPHM | RENEO PHARMACEUTICALS INC | 2 | 2 | 0.12% | 0.13% | 0.14% | Q2 2021 | Q3 2021 | 2 |
GENEDX HOLDINGS CORP | 2 | 2 | 0.10% | 0.13% | 0.16% | Q2 2023 | Q3 2023 | 2 | |
BITI | BIOTIE THERAPIES OYJ | 2 | 2 | 0.11% | 0.13% | 0.15% | Q2 2015 | Q3 2015 | 2 |
TRGT | TARGACEPT INC | 2 | 2 | 0.12% | 0.13% | 0.13% | Q4 2013 | Q1 2014 | 2 |
MGTX | MEIRAGTX HOLDINGS PLC | 2 | 2 | 0.09% | 0.12% | 0.16% | Q4 2018 | Q1 2019 | 2 |
IFRX | INFLARX NV | 2 | 2 | 0.09% | 0.12% | 0.14% | Q4 2017 | Q1 2018 | 2 |
INTERCEPT PHARMACEUTIC... | 1 | 1 | 0.07% | 0.11% | 0.15% | Q4 2019 | Q2 2020 | 2 | |
OSIR | OSIRIS THERAPEUTICS IN... | 2 | 2 | 0.03% | 0.10% | 0.18% | Q2 2014 | Q3 2014 | 2 |
EXEL | EXELIXIS INC | 1 | 1 | 0.06% | 0.10% | 0.15% | Q1 2014 | Q3 2016 | 2 |
OHPAU | ORION ACQUISITION CORP | 2 | 2 | 0.09% | 0.10% | 0.10% | Q1 2021 | Q2 2021 | 2 |
MANNKIND CORP | 2 | 2 | 0.10% | 0.10% | 0.10% | Q2 2013 | Q3 2013 | 2 | |
ELN | ELAN PLC | 2 | 2 | 0.07% | 0.09% | 0.11% | Q2 2013 | Q3 2013 | 2 |
TALK | TALKSPACE INC | 2 | 2 | 0.05% | 0.08% | 0.11% | Q2 2021 | Q3 2021 | 2 |
MDXG | MIMEDX GROUP INC | 2 | 2 | 0.07% | 0.08% | 0.08% | Q3 2017 | Q4 2017 | 2 |
IMMU | IMMUNOMEDICS INC | 2 | 2 | 0.06% | 0.07% | 0.09% | Q4 2014 | Q1 2015 | 2 |
OXBT | OXYGEN BIOTHERAPEUTICS... | 2 | 2 | 0.02% | 0.07% | 0.12% | Q1 2014 | Q2 2014 | 2 |
REGN | REGENERON PHARMACEUTICALS | 1 | 1 | 0.06% | 0.06% | 0.06% | Q1 2014 | Q3 2016 | 2 |
RMED | RA MED SYS INC | 2 | 2 | 0.04% | 0.06% | 0.08% | Q3 2018 | Q4 2018 | 2 |
NVDQ | NOVADAQ TECHNOLOGIES INC | 2 | 2 | 0.01% | 0.06% | 0.10% | Q4 2013 | Q1 2014 | 2 |
IRWD | IRONWOOD PHARMACEUTICA... | 2 | 2 | 0.05% | 0.05% | 0.06% | Q2 2013 | Q3 2013 | 2 |
GKOS | GLAUKOS CORP | 2 | 2 | 0.04% | 0.05% | 0.06% | Q4 2021 | Q1 2022 | 2 |
CTRX | CATAMARAN CORP | 2 | 2 | 0.03% | 0.05% | 0.07% | Q2 2013 | Q3 2013 | 2 |
PTBI | PLASMATECH BIOPHARMACE... | 2 | 2 | 0.04% | 0.04% | 0.05% | Q4 2014 | Q1 2015 | 2 |
SLXP | SALIX PHARMACEUTICALS INC | 2 | 2 | 0.03% | 0.04% | 0.05% | Q3 2014 | Q4 2014 | 2 |
SLTM | SOLTA MED INC | 2 | 2 | 0.03% | 0.03% | 0.04% | Q2 2013 | Q3 2013 | 2 |
ELGXQ | ENDOLOGIX INC | 2 | 2 | 0.02% | 0.02% | 0.02% | Q1 2020 | Q2 2020 | 2 |
IRWD | IRONWOOD PHARMACEUTICA... | 1 | 1 | 0.02% | 0.02% | 0.03% | Q3 2014 | Q2 2015 | 2 |
PRGO | PERRIGO CO PLC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q2 2014 | Q2 2015 | 2 |
OPK | OPKO HEALTH INC | 2 | 2 | 0.01% | 0.02% | 0.02% | Q2 2014 | Q3 2014 | 2 |
TRXC | TRANSENTERIX INC | 2 | 2 | 0.01% | 0.02% | 0.03% | Q2 2015 | Q3 2015 | 2 |
ICAD | ICAD INC | 2 | 2 | 0.01% | 0.01% | 0.01% | Q2 2013 | Q3 2013 | 2 |
PTBIW | PLASMATECH BIOPHARMACE... | 2 | 2 | 0.01% | 0.01% | 0.01% | Q4 2014 | Q1 2015 | 2 |
TBIO | TRANSGENOMIC INC | 2 | 2 | 0.01% | 0.01% | 0.01% | Q2 2014 | Q3 2014 | 2 |
HSGX | HISTOGENICS CORP | 2 | 2 | 0.00% | 0.00% | 0.01% | Q3 2018 | Q4 2018 | 2 |
INVITAE CORP | 1 | 1 | 5.22% | 5.22% | 5.22% | Q4 2020 | Q4 2020 | 1 | |
INVITAE CORP | 1 | 1 | 3.61% | 3.61% | 3.61% | Q3 2023 | Q3 2023 | 1 | |
SAREPTA THERAPEUTICS INC | 1 | 1 | 2.95% | 2.95% | 2.95% | Q3 2022 | Q3 2022 | 1 | |
AERIE PHARMACEUTICALS INC | 1 | 1 | 2.71% | 2.71% | 2.71% | Q4 2020 | Q4 2020 | 1 | |
BIIB | BIOGEN INC | 1 | 1 | 2.10% | 2.10% | 2.10% | Q2 2022 | Q2 2022 | 1 |
OPTR | OPTIMER PHARMACEUTICAL... | 1 | 1 | 2.06% | 2.06% | 2.06% | Q2 2013 | Q2 2013 | 1 |
INSULET CORP | 1 | 1 | 1.87% | 1.87% | 1.87% | Q2 2019 | Q2 2019 | 1 | |
APELLIS PHARMACEUTICAL... | 1 | 1 | 1.83% | 1.83% | 1.83% | Q4 2020 | Q4 2020 | 1 | |
ALXN | ALEXION PHARMACEUTICAL... | 1 | 1 | 1.79% | 1.79% | 1.79% | Q4 2020 | Q4 2020 | 1 |
INSULET CORP | 1 | 1 | 1.51% | 1.51% | 1.51% | Q4 2020 | Q4 2020 | 1 | |
BIO | BIO RAD LABS INC | 1 | 1 | 1.37% | 1.37% | 1.37% | Q3 2023 | Q3 2023 | 1 |
CTRX | CATAMARAN CORP | 1 | 1 | 1.26% | 1.26% | 1.26% | Q2 2013 | Q2 2013 | 1 |
ONTX | ONCONOVA THERAPEUTICS INC | 1 | 1 | 1.19% | 1.19% | 1.19% | Q3 2013 | Q3 2013 | 1 |
HEARTWARE INTL INC | 1 | 1 | 1.18% | 1.18% | 1.18% | Q2 2016 | Q2 2016 | 1 | |
DGX | QUEST DIAGNOSTICS INC | 1 | 1 | 1.04% | 1.04% | 1.04% | Q1 2014 | Q1 2014 | 1 |
WAG | WALGREEN CO | 1 | 1 | 1.04% | 1.04% | 1.04% | Q3 2014 | Q3 2014 | 1 |
FATE | FATE THERAPEUTICS INC | 1 | 1 | 1.01% | 1.01% | 1.01% | Q4 2020 | Q4 2020 | 1 |
CYTK | CYTOKINETICS INC | 1 | 1 | 0.97% | 0.97% | 0.97% | Q2 2013 | Q2 2013 | 1 |
OCDX | ORTHO CLINICAL DIAGNOS... | 1 | 1 | 0.95% | 0.95% | 0.95% | Q1 2021 | Q1 2021 | 1 |
SGRY | SURGERY PARTNERS INC | 1 | 1 | 0.94% | 0.94% | 0.94% | Q3 2023 | Q3 2023 | 1 |
STAA | STAAR SURGICAL CO | 1 | 1 | 0.92% | 0.92% | 0.92% | Q2 2019 | Q2 2019 | 1 |
DYNAVAX TECHNOLOGIES CORP | 1 | 1 | 0.92% | 0.92% | 0.92% | Q2 2022 | Q2 2022 | 1 | |
EVHC | ENVISION HEALTHCARE CORP | 1 | 1 | 0.92% | 0.92% | 0.92% | Q4 2017 | Q4 2017 | 1 |
INTERCEPT PHARMACEUTIC... | 1 | 1 | 0.90% | 0.90% | 0.90% | Q4 2020 | Q4 2020 | 1 | |
BPMC | BLUEPRINT MEDICINES CORP | 1 | 1 | 0.90% | 0.90% | 0.90% | Q4 2020 | Q4 2020 | 1 |
CLOVIS ONCOLOGY INC | 1 | 1 | 0.89% | 0.89% | 0.89% | Q4 2020 | Q4 2020 | 1 | |
MNKKQ | MALLINCKRODT PUB LTD CO | 1 | 1 | 0.82% | 0.82% | 0.82% | Q3 2014 | Q3 2014 | 1 |
COTV | COTIVITI HLDGS INC | 1 | 1 | 0.75% | 0.75% | 0.75% | Q2 2016 | Q2 2016 | 1 |
CBIO | CATALYST BIOSCIENCES INC | 1 | 1 | 0.74% | 0.74% | 0.74% | Q1 2018 | Q1 2018 | 1 |
HRC | HILL ROM HLDGS INC | 1 | 1 | 0.65% | 0.65% | 0.65% | Q1 2021 | Q1 2021 | 1 |
NOVAVAX INC | 1 | 1 | 0.62% | 0.62% | 0.62% | Q4 2020 | Q4 2020 | 1 | |
RMD | RESMED INC | 1 | 1 | 0.60% | 0.60% | 0.60% | Q4 2014 | Q4 2014 | 1 |
TCRR | TCR2 THERAPEUTICS INC | 1 | 1 | 0.59% | 0.59% | 0.59% | Q3 2020 | Q3 2020 | 1 |
STTK | SHATTUCK LABS INC | 1 | 1 | 0.57% | 0.57% | 0.57% | Q4 2020 | Q4 2020 | 1 |
JAZZ INVESTMENTS I LTD | 1 | 1 | 0.57% | 0.57% | 0.57% | Q2 2020 | Q2 2020 | 1 | |
RAYZEBIO INC | 1 | 1 | 0.57% | 0.57% | 0.57% | Q3 2023 | Q3 2023 | 1 | |
PTLA | PORTOLA PHARMACEUTICAL... | 1 | 1 | 0.57% | 0.57% | 0.57% | Q1 2018 | Q1 2018 | 1 |
PTLA | PORTOLA PHARMACEUTICAL... | 1 | 1 | 0.57% | 0.57% | 0.57% | Q1 2018 | Q1 2018 | 1 |
PACIRA BIOSCIENCES | 1 | 1 | 0.56% | 0.56% | 0.56% | Q3 2020 | Q3 2020 | 1 | |
IMPAX LABORATORIES INC | 1 | 1 | 0.54% | 0.54% | 0.54% | Q1 2017 | Q1 2017 | 1 | |
VERV | VERVE THERAPEUTICS INC | 1 | 1 | 0.51% | 0.51% | 0.51% | Q3 2022 | Q3 2022 | 1 |
PBYI | PUMA BIOTECHNOLOGY INC | 1 | 1 | 0.48% | 0.48% | 0.48% | Q2 2017 | Q2 2017 | 1 |
FIGS | FIGS INC | 1 | 1 | 0.48% | 0.48% | 0.48% | Q4 2021 | Q4 2021 | 1 |
IMS | IMS HEALTH HLDGS INC | 1 | 1 | 0.48% | 0.48% | 0.48% | Q2 2014 | Q2 2014 | 1 |
SGEN | SEATTLE GENETICS INC | 1 | 1 | 0.44% | 0.44% | 0.44% | Q2 2013 | Q2 2013 | 1 |
NNOX | NANO X IMAGING LTD | 1 | 1 | 0.44% | 0.44% | 0.44% | Q3 2020 | Q3 2020 | 1 |
ICPT | INTERCEPT PHARMACEUTIC... | 1 | 1 | 0.43% | 0.43% | 0.43% | Q3 2014 | Q3 2014 | 1 |
BHG | BRIGHT HEALTH GROUP INC | 1 | 1 | 0.43% | 0.43% | 0.43% | Q2 2021 | Q2 2021 | 1 |
GDRX | GOODRX HLDGS INC | 1 | 1 | 0.42% | 0.42% | 0.42% | Q1 2022 | Q1 2022 | 1 |
IONS | IONIS PHARMACEUTICALS INC | 1 | 1 | 0.42% | 0.42% | 0.42% | Q4 2016 | Q4 2016 | 1 |
PHAS | PHASEBIO PHARMACEUTICA... | 1 | 1 | 0.40% | 0.40% | 0.40% | Q2 2019 | Q2 2019 | 1 |
PRAX | PRAXIS PRECISION MEDIC... | 1 | 1 | 0.38% | 0.38% | 0.38% | Q4 2020 | Q4 2020 | 1 |
MAACU | MONTES ARCHIMEDES ACQU... | 1 | 1 | 0.38% | 0.38% | 0.38% | Q2 2021 | Q2 2021 | 1 |
CARIBOU BIOSCIENCES INC | 1 | 1 | 0.37% | 0.37% | 0.37% | Q3 2023 | Q3 2023 | 1 | |
NITE | NIGHTSTAR THERAPEUTICS... | 1 | 1 | 0.37% | 0.37% | 0.37% | Q3 2018 | Q3 2018 | 1 |
MAAC | MONTES ARCHIMEDES ACQU... | 1 | 1 | 0.36% | 0.36% | 0.36% | Q3 2021 | Q3 2021 | 1 |
ALLK | ALLAKOS INC | 1 | 1 | 0.36% | 0.36% | 0.36% | Q3 2018 | Q3 2018 | 1 |
MRNS | MARINUS PHARMACEUTICAL... | 1 | 1 | 0.36% | 0.36% | 0.36% | Q3 2017 | Q3 2017 | 1 |
ISEE | IVERIC BIO INC | 1 | 1 | 0.36% | 0.36% | 0.36% | Q3 2022 | Q3 2022 | 1 |
CMTA | CLEMENTIA PHARMACEUTIC... | 1 | 1 | 0.35% | 0.35% | 0.35% | Q3 2017 | Q3 2017 | 1 |
KERX | KERYX BIOPHARMACEUTICA... | 1 | 1 | 0.35% | 0.35% | 0.35% | Q3 2014 | Q3 2014 | 1 |
BBIO | BRIDGEBIO PHARMA INC | 1 | 1 | 0.35% | 0.35% | 0.35% | Q4 2021 | Q4 2021 | 1 |
PASG | PASSAGE BIO INC | 1 | 1 | 0.34% | 0.34% | 0.34% | Q1 2020 | Q1 2020 | 1 |
CHWY | CHEWY INC | 1 | 1 | 0.33% | 0.33% | 0.33% | Q2 2019 | Q2 2019 | 1 |
ALGS | ALIGOS THERAPEUTICS INC | 1 | 1 | 0.33% | 0.33% | 0.33% | Q4 2020 | Q4 2020 | 1 |
KROS | KEROS THERAPEUTICS INC | 1 | 1 | 0.33% | 0.33% | 0.33% | Q2 2020 | Q2 2020 | 1 |
ERASCA INC | 1 | 1 | 0.33% | 0.33% | 0.33% | Q3 2021 | Q3 2021 | 1 | |
WAGE | WAGEWORKS INC | 1 | 1 | 0.32% | 0.32% | 0.32% | Q3 2014 | Q3 2014 | 1 |
TARA | ARTARA THERAPEUTICS INC | 1 | 1 | 0.32% | 0.32% | 0.32% | Q1 2020 | Q1 2020 | 1 |
STXS | STEREOTAXIS INC | 1 | 1 | 0.32% | 0.32% | 0.32% | Q2 2021 | Q2 2021 | 1 |
LPTX | LEAP THERAPEUTICS INC | 1 | 1 | 0.31% | 0.31% | 0.31% | Q3 2021 | Q3 2021 | 1 |
JANX | JANUX THERAPEUTICS INC | 1 | 1 | 0.31% | 0.31% | 0.31% | Q2 2021 | Q2 2021 | 1 |
RUBY | RUBIUS THERAPEUTICS INC | 1 | 1 | 0.31% | 0.31% | 0.31% | Q1 2021 | Q1 2021 | 1 |
ANTH | ANTHERA PHARMACEUTICAL... | 1 | 1 | 0.30% | 0.30% | 0.30% | Q2 2013 | Q2 2013 | 1 |
ORIC | ORIC PHARMACEUTICALS INC | 1 | 1 | 0.30% | 0.30% | 0.30% | Q2 2020 | Q2 2020 | 1 |
CEPHEID | 1 | 1 | 0.30% | 0.30% | 0.30% | Q1 2016 | Q1 2016 | 1 | |
ACELYRIN INC | 1 | 1 | 0.29% | 0.29% | 0.29% | Q2 2023 | Q2 2023 | 1 | |
TBIO | TRANSLATE BIO INC | 1 | 1 | 0.29% | 0.29% | 0.29% | Q2 2018 | Q2 2018 | 1 |
BSX | BOSTON SCIENTIFIC CORP | 1 | 1 | 0.29% | 0.29% | 0.29% | Q4 2020 | Q4 2020 | 1 |
CDAK | CODIAK BIOSCIENCES INC | 1 | 1 | 0.29% | 0.29% | 0.29% | Q4 2020 | Q4 2020 | 1 |
INCY | INCYTE CORP | 1 | 1 | 0.29% | 0.29% | 0.29% | Q2 2016 | Q2 2016 | 1 |
THESEUS PHARMACEUTICAL... | 1 | 1 | 0.28% | 0.28% | 0.28% | Q2 2023 | Q2 2023 | 1 | |
AUXL | AUXILIUM PHARMACEUTICA... | 1 | 1 | 0.28% | 0.28% | 0.28% | Q1 2014 | Q1 2014 | 1 |
SRRK | SCHOLAR ROCK HLDG CORP | 1 | 1 | 0.28% | 0.28% | 0.28% | Q4 2020 | Q4 2020 | 1 |
CNXR | CONNECTURE INC | 1 | 1 | 0.26% | 0.26% | 0.26% | Q4 2014 | Q4 2014 | 1 |
IOVA | IOVANCE BIOTHERAPEUTIC... | 1 | 1 | 0.25% | 0.25% | 0.25% | Q1 2023 | Q1 2023 | 1 |
SGFY | SIGNIFY HEALTH INC | 1 | 1 | 0.25% | 0.25% | 0.25% | Q1 2021 | Q1 2021 | 1 |
GERN | GERON CORP | 1 | 1 | 0.25% | 0.25% | 0.25% | Q4 2013 | Q4 2013 | 1 |
ECOR | ELECTROCORE INC | 1 | 1 | 0.25% | 0.25% | 0.25% | Q2 2018 | Q2 2018 | 1 |
ARMO | ARMO BIOSCIENCES INC | 1 | 1 | 0.24% | 0.24% | 0.24% | Q1 2018 | Q1 2018 | 1 |
BOLT | BOLT BIOTHERAPEUTICS INC | 1 | 1 | 0.24% | 0.24% | 0.24% | Q1 2021 | Q1 2021 | 1 |
QUIDELORTHO CORP | 1 | 1 | 0.24% | 0.24% | 0.24% | Q3 2023 | Q3 2023 | 1 | |
ALNA | ALLENA PHARMACEUTICALS... | 1 | 1 | 0.24% | 0.24% | 0.24% | Q4 2017 | Q4 2017 | 1 |
WOOF | PETCO HEALTH & WELLNES... | 1 | 1 | 0.23% | 0.23% | 0.23% | Q1 2021 | Q1 2021 | 1 |
LIANBIO | 1 | 1 | 0.23% | 0.23% | 0.23% | Q4 2021 | Q4 2021 | 1 | |
VERA | VERA THERAPEUTICS INC | 1 | 1 | 0.22% | 0.22% | 0.22% | Q1 2023 | Q1 2023 | 1 |
SLDB | SOLID BIOSCIENCES INC | 1 | 1 | 0.22% | 0.22% | 0.22% | Q2 2018 | Q2 2018 | 1 |
RXSIGHT INC | 1 | 1 | 0.22% | 0.22% | 0.22% | Q3 2021 | Q3 2021 | 1 | |
CNVY | CONVEY HLDG PARENT INC | 1 | 1 | 0.22% | 0.22% | 0.22% | Q2 2021 | Q2 2021 | 1 |
GOCO | GOHEALTH INC | 1 | 1 | 0.22% | 0.22% | 0.22% | Q3 2020 | Q3 2020 | 1 |
SRPT | SAREPTA THERAPEUTICS INC | 1 | 1 | 0.22% | 0.22% | 0.22% | Q3 2013 | Q3 2013 | 1 |
SSH | SUNSHINE HEART INC | 1 | 1 | 0.22% | 0.22% | 0.22% | Q4 2013 | Q4 2013 | 1 |
AGL | AGILON HEALTH INC | 1 | 1 | 0.22% | 0.22% | 0.22% | Q2 2021 | Q2 2021 | 1 |
TYRA BIOSCIENCES INC | 1 | 1 | 0.22% | 0.22% | 0.22% | Q3 2021 | Q3 2021 | 1 | |
XOMA | XOMA CORP DEL | 1 | 1 | 0.21% | 0.21% | 0.21% | Q1 2014 | Q1 2014 | 1 |
AKUS | AKOUOS INC | 1 | 1 | 0.21% | 0.21% | 0.21% | Q2 2020 | Q2 2020 | 1 |
MRSN | MERSANA THERAPEUTICS INC | 1 | 1 | 0.20% | 0.20% | 0.20% | Q2 2023 | Q2 2023 | 1 |
PRVB | PROVENTION BIO INC | 1 | 1 | 0.20% | 0.20% | 0.20% | Q3 2019 | Q3 2019 | 1 |
ATHA | ATHIRA PHARMA INC | 1 | 1 | 0.20% | 0.20% | 0.20% | Q3 2020 | Q3 2020 | 1 |
SRNE | SORRENTO THERAPEUTICS INC | 1 | 1 | 0.20% | 0.20% | 0.20% | Q2 2019 | Q2 2019 | 1 |
BCYC | BICYCLE THERAPEUTICS PLC | 1 | 1 | 0.20% | 0.20% | 0.20% | Q3 2023 | Q3 2023 | 1 |
LFST | LIFESTANCE HEALTH GROU... | 1 | 1 | 0.20% | 0.20% | 0.20% | Q2 2021 | Q2 2021 | 1 |
TANGO THERAPEUTICS INC | 1 | 1 | 0.20% | 0.20% | 0.20% | Q3 2023 | Q3 2023 | 1 | |
VCRA | VOCERA COMMUNICATIONS INC | 1 | 1 | 0.19% | 0.19% | 0.19% | Q2 2013 | Q2 2013 | 1 |
ESRX | EXPRESS SCRIPTS HLDG CO | 1 | 1 | 0.19% | 0.19% | 0.19% | Q3 2013 | Q3 2013 | 1 |
CUE HEALTH INC | 1 | 1 | 0.18% | 0.18% | 0.18% | Q3 2021 | Q3 2021 | 1 | |
AUPH | AURINIA PHARMACEUTICAL... | 1 | 1 | 0.18% | 0.18% | 0.18% | Q3 2021 | Q3 2021 | 1 |
IGMS | IGM BIOSCIENCES INC | 1 | 1 | 0.18% | 0.18% | 0.18% | Q3 2019 | Q3 2019 | 1 |
WEAVE COMMUNICATIONS INC | 1 | 1 | 0.18% | 0.18% | 0.18% | Q4 2021 | Q4 2021 | 1 | |
ITOS | ITEOS THERAPEUTICS INC | 1 | 1 | 0.17% | 0.17% | 0.17% | Q3 2023 | Q3 2023 | 1 |
CLLS | CELLECTIS S A | 1 | 1 | 0.17% | 0.17% | 0.17% | Q1 2015 | Q1 2015 | 1 |
EIGR | EIGER BIOPHARMACEUTICA... | 1 | 1 | 0.16% | 0.16% | 0.16% | Q4 2017 | Q4 2017 | 1 |
MNKD | MANNKIND CORP | 1 | 1 | 0.16% | 0.16% | 0.16% | Q1 2014 | Q1 2014 | 1 |
ACORDA THERAPEUTICS INC | 1 | 1 | 0.16% | 0.16% | 0.16% | Q1 2017 | Q1 2017 | 1 | |
INNV | INNOVAGE HLDG CORP | 1 | 1 | 0.16% | 0.16% | 0.16% | Q1 2021 | Q1 2021 | 1 |
PEN | PENUMBRA INC | 1 | 1 | 0.16% | 0.16% | 0.16% | Q3 2015 | Q3 2015 | 1 |
PNT | POINT BIOPHARMA GLOBAL... | 1 | 1 | 0.15% | 0.15% | 0.15% | Q3 2022 | Q3 2022 | 1 |
HYPERFINE INC | 1 | 1 | 0.15% | 0.15% | 0.15% | Q4 2021 | Q4 2021 | 1 | |
BCRX | BIOCRYST PHARMACEUTICALS | 1 | 1 | 0.15% | 0.15% | 0.15% | Q2 2017 | Q2 2017 | 1 |
INFI | INFINITY PHARMACEUTICA... | 1 | 1 | 0.14% | 0.14% | 0.14% | Q4 2013 | Q4 2013 | 1 |
GLUE | MONTE ROSA THERAPEUTIC... | 1 | 1 | 0.14% | 0.14% | 0.14% | Q2 2021 | Q2 2021 | 1 |
GRCL | GRACELL BIOTECHNOLOGIE... | 1 | 1 | 0.13% | 0.13% | 0.13% | Q1 2021 | Q1 2021 | 1 |
MANNKIND CORP | 1 | 1 | 0.13% | 0.13% | 0.13% | Q2 2013 | Q2 2013 | 1 | |
CERE | CEREVEL THERAPEUTICS H... | 1 | 1 | 0.13% | 0.13% | 0.13% | Q4 2020 | Q4 2020 | 1 |
ALBANY MOLECULAR RESH INC | 1 | 1 | 0.12% | 0.12% | 0.12% | Q4 2013 | Q4 2013 | 1 | |
RTRX | RETROPHIN INC | 1 | 1 | 0.12% | 0.12% | 0.12% | Q1 2015 | Q1 2015 | 1 |
SQNM | SEQUENOM INC | 1 | 1 | 0.12% | 0.12% | 0.12% | Q3 2013 | Q3 2013 | 1 |
ADPT | ADAPTIVE BIOTECHNOLOGI... | 1 | 1 | 0.12% | 0.12% | 0.12% | Q2 2019 | Q2 2019 | 1 |
SNSE | SENSEI BIOTHERAPEUTICS... | 1 | 1 | 0.12% | 0.12% | 0.12% | Q1 2021 | Q1 2021 | 1 |
SCMP | SUCAMPO PHARMACEUTICAL... | 1 | 1 | 0.11% | 0.11% | 0.11% | Q1 2015 | Q1 2015 | 1 |
CTIC | CTI BIOPHARMA CORP | 1 | 1 | 0.11% | 0.11% | 0.11% | Q4 2015 | Q4 2015 | 1 |
EAR | EARGO INC | 1 | 1 | 0.11% | 0.11% | 0.11% | Q4 2020 | Q4 2020 | 1 |
TCMD | TACTILE SYS TECHNOLOGY... | 1 | 1 | 0.10% | 0.10% | 0.10% | Q1 2018 | Q1 2018 | 1 |
LGVWWS | LONGVIEW ACQUISITION CORP | 1 | 1 | 0.10% | 0.10% | 0.10% | Q4 2020 | Q4 2020 | 1 |
INTERCEPT PHARMACEUTIC... | 1 | 1 | 0.09% | 0.09% | 0.09% | Q1 2020 | Q1 2020 | 1 | |
CLDX | CELLDEX THERAPEUTICS I... | 1 | 1 | 0.09% | 0.09% | 0.09% | Q4 2016 | Q4 2016 | 1 |
LABP | LANDOS BIOPHARMA INC | 1 | 1 | 0.09% | 0.09% | 0.09% | Q1 2021 | Q1 2021 | 1 |
TVTY | TIVITY HEALTH INC | 1 | 1 | 0.08% | 0.08% | 0.08% | Q1 2017 | Q1 2017 | 1 |
MASS | 908 DEVICES INC | 1 | 1 | 0.08% | 0.08% | 0.08% | Q4 2020 | Q4 2020 | 1 |
AERI | AERIE PHARMACEUTICALS INC | 1 | 1 | 0.08% | 0.08% | 0.08% | Q4 2019 | Q4 2019 | 1 |
ARWR | ARROWHEAD RESH CORP | 1 | 1 | 0.08% | 0.08% | 0.08% | Q4 2013 | Q4 2013 | 1 |
FLXN | FLEXION THERAPEUTICS INC | 1 | 1 | 0.07% | 0.07% | 0.07% | Q4 2014 | Q4 2014 | 1 |
WGBS | WAFERGEN BIO-SYSTEMS INC | 1 | 1 | 0.07% | 0.07% | 0.07% | Q3 2014 | Q3 2014 | 1 |
PYXIS ONCOLOGY INC | 1 | 1 | 0.07% | 0.07% | 0.07% | Q4 2021 | Q4 2021 | 1 | |
LJPC | LA JOLLA PHARMACEUTICA... | 1 | 1 | 0.07% | 0.07% | 0.07% | Q3 2015 | Q3 2015 | 1 |
BMEA | BIOMEA FUSION INC | 1 | 1 | 0.07% | 0.07% | 0.07% | Q2 2021 | Q2 2021 | 1 |
IRTC | IRHYTHM TECHNOLOGIES INC | 1 | 1 | 0.07% | 0.07% | 0.07% | Q3 2021 | Q3 2021 | 1 |
CHNG | CHANGE HEALTHCARE INC | 1 | 1 | 0.07% | 0.07% | 0.07% | Q1 2020 | Q1 2020 | 1 |
INNL | INNOCOLL HLDGS PLC | 1 | 1 | 0.07% | 0.07% | 0.07% | Q2 2016 | Q2 2016 | 1 |
ASNS | ARSANIS INC | 1 | 1 | 0.07% | 0.07% | 0.07% | Q4 2017 | Q4 2017 | 1 |
SNSS | SUNESIS PHARMACEUTICAL... | 1 | 1 | 0.06% | 0.06% | 0.06% | Q4 2013 | Q4 2013 | 1 |
GNMK | GENMARK DIAGNOSTICS INC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q3 2020 | Q3 2020 | 1 |
AMGN | AMGEN INC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q4 2013 | Q4 2013 | 1 |
NVLNF | NOVELION THERAPEUTICS INC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q4 2016 | Q4 2016 | 1 |
A | AGILENT TECHNOLOGIES INC | 1 | 1 | 0.06% | 0.06% | 0.06% | Q1 2014 | Q1 2014 | 1 |
AVEO | AVEO PHARMACEUTICALS INC | 1 | 1 | 0.05% | 0.05% | 0.05% | Q2 2020 | Q2 2020 | 1 |
MOLINA HEALTHCARE INC | 1 | 1 | 0.05% | 0.05% | 0.05% | Q2 2014 | Q2 2014 | 1 | |
MLNTQ | MELINTA THERAPEUTICS INC | 1 | 1 | 0.05% | 0.05% | 0.05% | Q1 2019 | Q1 2019 | 1 |
GTXI | GTX INC DEL | 1 | 1 | 0.05% | 0.05% | 0.05% | Q3 2013 | Q3 2013 | 1 |
FURX | FURIEX PHARMACEUTICALS... | 1 | 1 | 0.05% | 0.05% | 0.05% | Q1 2014 | Q1 2014 | 1 |
ELEV | ELEVATION ONCOLOGY INC | 1 | 1 | 0.04% | 0.04% | 0.04% | Q2 2023 | Q2 2023 | 1 |
VRAY | VIEWRAY INC | 1 | 1 | 0.04% | 0.04% | 0.04% | Q3 2019 | Q3 2019 | 1 |
TEAR | TEARLAB CORP | 1 | 1 | 0.04% | 0.04% | 0.04% | Q3 2014 | Q3 2014 | 1 |
ARTC | ARTHROCARE CORP | 1 | 1 | 0.04% | 0.04% | 0.04% | Q4 2013 | Q4 2013 | 1 |
ZTS | ZOETIS INC | 1 | 1 | 0.04% | 0.04% | 0.04% | Q4 2014 | Q4 2014 | 1 |
GTIV | GENTIVA HEALTH SERVICE... | 1 | 1 | 0.04% | 0.04% | 0.04% | Q2 2013 | Q2 2013 | 1 |
ETNB | 89BIO INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q2 2022 | Q2 2022 | 1 |
WCG | WELLCARE HEALTH PLANS INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q3 2014 | Q3 2014 | 1 |
MDVN | MEDIVATION INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q1 2014 | Q1 2014 | 1 |
DFHTW | DEERFIELD HEALTHCARE T... | 1 | 1 | 0.03% | 0.03% | 0.03% | Q1 2021 | Q1 2021 | 1 |
AQXP | AQUINOX PHARMACEUTICAL... | 1 | 1 | 0.03% | 0.03% | 0.03% | Q1 2014 | Q1 2014 | 1 |
CYNA | CYNAPSUS THERAPEUTICS INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q2 2016 | Q2 2016 | 1 |
WCRX | WARNER CHILCOTT PLC IR... | 1 | 1 | 0.03% | 0.03% | 0.03% | Q2 2013 | Q2 2013 | 1 |
AVNR | AVANIR PHARMACEUTICALS... | 1 | 1 | 0.03% | 0.03% | 0.03% | Q3 2013 | Q3 2013 | 1 |
CRVS | CORVUS PHARMACEUTICALS... | 1 | 1 | 0.03% | 0.03% | 0.03% | Q1 2017 | Q1 2017 | 1 |
MAACW | MONTES ARCHIMEDES ACQU... | 1 | 1 | 0.03% | 0.03% | 0.03% | Q3 2021 | Q3 2021 | 1 |
MLND | MILLENDO THERAPEUTICS INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q1 2020 | Q1 2020 | 1 |
SPHS | SOPHIRIS BIO INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q3 2013 | Q3 2013 | 1 |
SNN | SMITH & NEPHEW PLC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q2 2014 | Q2 2014 | 1 |
HALO | HALOZYME THERAPEUTICS INC | 1 | 1 | 0.03% | 0.03% | 0.03% | Q3 2015 | Q3 2015 | 1 |
MYGN | MYRIAD GENETICS INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q2 2013 | Q2 2013 | 1 |
CALCIMEDICA INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q2 2023 | Q2 2023 | 1 | |
PTXTQ | PERNIX THERAPEUTICS HL... | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2018 | Q3 2018 | 1 |
CUTR | CUTERA INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2023 | Q3 2023 | 1 |
BRKR | BRUKER CORP | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2013 | Q3 2013 | 1 |
ICLR | ICON PLC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q2 2014 | Q2 2014 | 1 |
ABT | ABBOTT LABS | 1 | 1 | 0.02% | 0.02% | 0.02% | Q1 2015 | Q1 2015 | 1 |
LHCG | LHC GROUP INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q2 2013 | Q2 2013 | 1 |
ENDP | ENDO INTL PLC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q2 2016 | Q2 2016 | 1 |
AEZS | AETERNA ZENTARIS INC | 1 | 1 | 0.02% | 0.02% | 0.02% | Q1 2015 | Q1 2015 | 1 |
EYPT | EYEPOINT PHARMACEUTICA... | 1 | 1 | 0.02% | 0.02% | 0.02% | Q1 2019 | Q1 2019 | 1 |
OPHT | OPHTHOTECH CORP | 1 | 1 | 0.02% | 0.02% | 0.02% | Q3 2015 | Q3 2015 | 1 |
RCPT | RECEPTOS INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q2 2015 | Q2 2015 | 1 |
CELG | CELGENE CORP | 1 | 1 | 0.01% | 0.01% | 0.01% | Q1 2015 | Q1 2015 | 1 |
ABC | AMERISOURCEBERGEN CORP | 1 | 1 | 0.01% | 0.01% | 0.01% | Q4 2015 | Q4 2015 | 1 |
AFAM | ALMOST FAMILY INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q2 2013 | Q2 2013 | 1 |
ALIMERA SCIENCES INC | 1 | 1 | 0.01% | 0.01% | 0.01% | Q3 2020 | Q3 2020 | 1 | |
TRISALUS LIFE SCIENCES... | 1 | 1 | 0.00% | 0.00% | 0.00% | Q3 2023 | Q3 2023 | 1 | |
PEAK BIO INC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q4 2022 | Q4 2022 | 1 | |
MEDAVAIL HOLDINGS INC | 1 | 1 | 0.00% | 0.00% | 0.00% | Q3 2023 | Q3 2023 | 1 | |
TRISALUS LIFE SCIENCES... | 1 | 1 | 0.00% | 0.00% | 0.00% | Q3 2023 | Q3 2023 | 1 | |
Download |
The securities at the top of the list , including AERIE PHARMACEUTICALS INC, CENTENE CORP DEL, and BIOCRYST PHARMACEUTICALS INC, are the highest-conviction holdings of DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C).
The conviction is calculated by counting the number of quarters a security has been reported by DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C). The higher the number, the higher the conviction and longer the holding period.
This page lists all the securities that DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) owns currently or has owned in the past.